Melanocytic naevi

CD2_BENIGN_MELANOCYTIC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22 Cause of death: ICD-10 — D22 2 out of 7 registries used, show all original rules.	13248
4. Check minimum number of events None	13248
5. Include endpoints CD2_BENIGN_MELANOCYTIC_LIP CD2_BENIGN_MELANOCYTIC_EYELID CD2_BENIGN_MELANOCYTIC_EAR CD2_BENIGN_MELANOCYTIC_FACE CD2_BENIGN_MELANOCYTIC_SCALPNECK CD2_BENIGN_MELANOCYTIC_TRUNK CD2_BENIGN_MELANOCYTIC_UPPERLIMB CD2_BENIGN_MELANOCYTIC_LOWERLIMB CD2_BENIGN_MELANOCYTIC_NOS	13740
6. Filter based on genotype QC (FinnGen only)	13740

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Naevi melanocytici

NAME	CD2_BENIGN_MELANOCYTIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_MELANOCYTIC_LIP\|CD2_BENIGN_MELANOCYTIC_EYELID\|CD2_BENIGN_MELANOCYTIC_EAR\|CD2_BENIGN_MELANOCYTIC_FACE\|CD2_BENIGN_MELANOCYTIC_SCALPNECK\|CD2_BENIGN_MELANOCYTIC_TRUNK\|CD2_BENIGN_MELANOCYTIC_UPPERLIMB\|CD2_BENIGN_MELANOCYTIC_LOWERLIMB\|CD2_BENIGN_MELANOCYTIC_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D22
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D22
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	88627	53433	34898
Only index persons	83857	51178	32679
Unadjusted period prevalence (%)
Whole population	1.31	1.53	0.98
Only index persons	1.63	1.88	1.25
Median age at first event (years)
Whole population	43.66	42.40	45.59
Only index persons	44.06	42.70	46.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13740	8954	4786
Unadjusted period prevalence (%)	2.72	3.05	2.11
Median age at first event (years)	51.05	46.68	59.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12163: Matched controls
121628

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D22

ICD-10 Finland

Melanocytic naevi

8.0

323.0

1590

2242

L82

ICD-10 Finland

Seborrhoeic keratosis

3.0

323.0

2382

9021

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

35.6

323.0

1440

457

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.4

323.0

2821

4793

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

22.1

323.0

789

380

L57.0

ICD-10 Finland

Actinic keratosis

4.3

323.0

1655

4283

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

12.8

323.0

1194

1027

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

8.2

323.0

2624

3965

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

55.0

323.0

2081

455

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

5.3

323.0

1336

2770

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

19.9

323.0

853

459

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

11.5

323.0

2927

3250

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

9.1

323.0

787

913

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

22.4

323.0

3097

1825

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

30.1

323.0

4480

2314

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.8

312.9

2392

9815

XQ845

NOMESCO Finland

Dermatoscopy

15.5

300.3

508

340

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

23.9

283.5

412

178

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

7.6

260.2

642

887

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

4.3

258.1

1041

2594

TQW99

NOMESCO Finland

Other minor procedure on skin

4.6

257.9

958

2200

XQ848

NOMESCO Finland

Dermatological photography

7.0

249.8

654

985

D22.1

ICD-10 Finland

Melanocytic naevi of eyelid, including canthus

43.7

239.1

299

D22.0

ICD-10 Finland

Melanocytic naevi of lip

63.4

233.0

273

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

6.6

217.8

591

933

2165A

ICD-9 Finland

Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

183.8

176

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

112.3

172.6

188

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

15.0

168.2

287

195

S18

ICPC

Laceration/cut

1.7

167.2

4782

33005

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

6.3

165.8

462

753

9733

FHL

Excision of skin change in operating room or anesthesia

8.4

165.2

378

461

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

16.2

163.6

271

171

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

6.1

160.9

459

771

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

3.4

157.2

829

2564

127

Kela drug reimbursment

Transplant complication

7.5

156.0

384

525

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

19.3

155.9

242

128

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

47.9

154.1

189

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

18.8

150.7

236

128

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

5.7

149.1

452

819

S82

ICPC

Naevus/mole

2.2

139.8

1650

8165

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.4

139.1

439

834

ZXC50

NOMESCO Finland

Cryotherapy

4.8

138.8

491

1059

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.0

135.7

349

509

Z94.0

ICD-10 Finland

Kidney transplant status

8.6

127.7

288

343

SPAT1153

SPAT

Removal of sutures

1.7

126.4

3585

24146

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

25.8

122.4

173

D03.5

ICD-10 Finland

Melanoma in situ of trunk

27.0

120.4

168

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

13.1

117.3

212

165

L04AA06

ATC

mycophenolic acid; systemic

5.6

114.8

350

638

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

6.3

112.0

311

504

PJA12

NOMESCO Finland

Sentinel node biopsy

2.5

109.6

976

4181

ZZR00

NOMESCO Finland

Flap of skin

4.8

107.7

375

794

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.1

105.8

206

188

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.9

100.1

431

1122

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

8.0

89.5

209

264

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

3.6

85.7

409

1162

2167A

ICD-9 Finland

Benign neoplasm of skin, Skin of lower limb, including hip[ALARAAJAN IHON BEN KASV,NAEVUS PIGMENTOSUS]

+∞

84.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

14.2

84.2

146

104

L04AD01

ATC

ciclosporin; systemic

4.2

81.9

327

795

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

7.8

80.2

190

246

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

16.6

78.6

128

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

16.9

78.5

127

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

78.4

316

775

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

22.1

77.4

114

2163A

ICD-9 Finland

Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

77.1

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

23.2

74.4

108

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

9.1

74.1

160

178

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.8

73.4

192

288

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

5.4

72.9

228

429

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.1

72.9

299

745

137

Kela drug reimbursment

Uraemia requiring dialysis

7.1

72.4

182

258

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

8.7

70.3

156

182

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

32.3

70.2

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

18.5

69.1

108

E0000UV

ATC

1.4

68.4

4331

33940

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

6.5

68.1

183

285

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

3.5

67.6

339

1002

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

12.0

63.4

118

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

16.1

63.4

104

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.4

63.2

198

374

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

13.5

62.9

111

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

32.1

62.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

4.4

61.9

236

550

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

5.5

60.9

188

349

L04AA01

ATC

[U] ciclosporin; systemic

4.3

59.6

233

556

A12AA04

ATC

calcium carbonate; oral

4.4

59.0

223

515

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

6.9

58.1

149

218

D06BB10

ATC

imiquimod; topical

2.3

58.1

561

2487

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.3

57.1

130

159

J01DB01

ATC

cefalexin; oral

1.4

55.9

9326

85048

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

15.7

55.6

A11CC03

ATC

alfacalcidol; systemic

3.4

55.0

278

828

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

17.5

54.9

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

8.9

54.0

117

132

ZQZ00

NOMESCO Finland

Treatment of several skin areas

8.6

53.8

119

139

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.8

51.9

360

1330

C43

ICD-10 Finland

Malignant melanoma of skin

13.2

51.9

ZXA00

NOMESCO Finland

Right side

1.4

49.9

2557

18990

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

49.8

1798

12408

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

6.5

49.7

133

207

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

14.0

49.7

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

49.6

326

1166

L04AX01

ATC

azathioprine; systemic

2.2

49.2

514

2365

B07.9

ICD-10 Finland

Verruca simplex

2.4

48.7

422

1769

B05DA

ATC

Isotonic solutions

6.3

48.7

133

213

ZXA05

NOMESCO Finland

Left side

1.4

48.7

2378

17487

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.8

48.6

329

1199

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

4.5

48.5

177

396

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

10.2

48.2

TK800

NOMESCO Finland

Hemodialysis

3.3

46.5

248

770

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.6

46.3

138

247

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

11.9

44.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

44.4

3915

31797

S29

ICPC

Skin symptom/complaint other

1.5

43.5

1644

11430

S77

ICPC

Malignant neoplasm of skin

4.7

43.1

151

325

180

Kela drug reimbursment

Interferon alfa

11.5

42.4

R4110

NOMESCO Finland

Physiotherapy

1.4

41.8

2560

19549

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

13.7

41.4

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

20.1

41.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

40.9

4029

33168

2166A

ICD-9 Finland

Benign neoplasm of skin, Skin of upper limb, including shoulder[YLÄRAAJAN IHON BEN KASV,NAEVUS PIGMENTOSUS]

+∞

40.6

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

11.6

40.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.4

40.3

151

348

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

40.2

580

3047

J01MA02

ATC

ciprofloxacin; systemic

1.3

39.9

3699

30145

S21

ICPC

Skin texture symptom/complaint

1.6

39.7

1193

7851

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

7.4

39.3

129

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

7.8

39.3

119

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

39.0

2890

22740

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

39.0

2680

20830

DHB00

NOMESCO Finland

Excision of lesion of external nose

5.0

38.8

128

259

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

38.6

594

3199

A98

ICPC

Health maint/preventive medicine

1.7

38.5

11519

111231

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

38.5

2095

15634

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

6.1

38.1

106

175

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.4

38.1

143

331

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

4.5

38.0

137

304

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

9.6

37.7

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.6

37.7

133

289

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

15.2

37.3

Z49.2

ICD-10 Finland

Other dialysis

5.4

37.2

115

216

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

37.2

199

621

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.9

36.1

154

401

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

24.4

36.1

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.1

36.0

207

680

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

35.8

149

380

UJF32

NOMESCO Finland

Coloscopy

1.4

35.6

2317

17806

B05DB

ATC

Hypertonic solutions

6.0

35.5

100

168

ZZA00

NOMESCO Finland

Split skin graft

2.5

35.3

283

1141

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

18.7

35.2

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.6

35.0

124

271

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

19.0

34.7

J01FA10

ATC

azithromycin; systemic

1.3

34.5

6414

56973

2164A

ICD-9 Finland

Benign neoplasm of skin, Scalp and skin of neck[PÄÄN JA KAULAN IHON BEN KASV,NAEVUS PIGMENTOSUS]

+∞

34.4

N02BE01

ATC

paracetamol; systemic, rectal

1.3

34.0

9490

88714

L91.0

ICD-10 Finland

Hypertrophic scar

3.2

33.7

185

589

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

6.3

33.7

145

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

33.4

1261

8726

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.1

33.0

107

213

R01AD09

ATC

mometasone; nasal

1.3

33.0

4763

40920

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

33.0

3346

27450

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

32.9

717

4317

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

4.6

32.7

115

250

J02AC01

ATC

fluconazole; systemic

1.3

32.6

4299

36497

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

32.5

2620

20789

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.2

32.2

329

1498

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

32.2

1533

11116

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.9

32.1

458

2397

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

18.9

32.1

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

3.7

31.8

144

396

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

6.4

31.7

131

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

7.5

31.6

100

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.5

31.6

259

1059

7151

FHL

Kidney transplantation

24.5

31.3

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

17.6

31.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

31.1

410

2080

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

5.3

30.7

180

A02BC02

ATC

pantoprazole; systemic

1.2

30.6

6534

58602

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

4.6

30.4

107

233

ZXC20

NOMESCO Finland

Use of chemical agents

2.8

30.4

199

715

B03XA01

ATC

erythropoietin; parenteral

4.7

29.7

103

221

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

29.7

583

3404

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

29.0

235

953

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

25.1

28.7

ZXA10

NOMESCO Finland

Bilateral

1.4

28.6

1664

12493

H02AB04

ATC

methylprednisolone; systemic

1.4

28.6

1339

9669

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

28.5

2271

17932

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

29.3

28.4

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

29.3

28.4

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

12.5

28.4

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

4.0

28.3

114

284

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

28.2

424

2263

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

4.6

28.2

216

2160A

ICD-9 Finland

Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]

+∞

28.1

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.1

28.1

126

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.4

27.9

247

1049

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.1

27.8

310

1471

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

14.9

27.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

27.6

2008

15630

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

28.5

27.5

Z94.4

ICD-10 Finland

Liver transplant status

7.0

27.5

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

27.2

1050

7290

F16

ICPC

Eyelid symptom/complaint

1.8

27.1

458

2550

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

27.0

2115

16638

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

18.7

26.9

L01XE23

ATC

[U] dabrafenib; oral

18.7

26.9

UKC02

NOMESCO Finland

Cystoscopy

1.4

26.7

1276

9237

D07AC01

ATC

betamethasone; topical

1.3

26.5

3241

27077

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

8.0

26.5

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

19.1

26.4

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

26.4

2883

23745

A02BC05

ATC

esomeprazole; systemic

1.2

26.3

3895

33289

J01CA04

ATC

amoxicillin; systemic

1.3

26.3

9125

85652

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

26.1

950

6505

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

25.7

2706

22169

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

25.6

1153

8256

V03AE02

ATC

sevelamer; oral

5.2

25.5

155

J05AB11

ATC

valaciclovir; oral

1.4

25.5

1224

8866

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

4.4

25.4

212

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.1

25.4

160

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

22.6

25.1

J05AB01

ATC

aciclovir; systemic

1.3

25.1

2005

15802

D18.0

ICD-10 Finland

Haemangioma, any site

2.4

24.6

220

943

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

6.1

24.5

110

TK820

NOMESCO Finland

Peritoneal dialysis

5.7

24.4

126

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

24.0

781

5219

2168A

ICD-9 Finland

Benign neoplasm of skin, Other specified sites of skin[IHON BEN KASV MUUALLA,NAEVUS PIGMENTOSUS]

+∞

24.0

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

4.7

23.7

177

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

13.8

23.5

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

19.5

23.4

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

19.5

23.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

23.4

3602

30823

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.6

23.3

108

305

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

23.3

263

1255

J01AA02

ATC

doxycycline; systemic

1.2

23.3

8189

76278

D01AE16

ATC

amorolfine; topical

1.5

23.2

981

6930

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

5.3

23.1

135

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

6.7

23.0

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

15.5

22.7

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

40.1

22.6

WX002

NOMESCO Finland

Sedation and analgesia

1.3

22.5

1720

13446

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

20.7

22.5

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

22.4

5316

47525

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

22.3

720

4799

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

11.1

22.3

A02BC01

ATC

omeprazole; systemic

1.3

22.1

2480

20419

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

22.1

214

954

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

17.9

22.1

9734

FHL

Excision and local plastic or associated free skin grafting

3.9

21.9

230

ZZA50

NOMESCO Finland

Full thickness skin graft

4.9

21.9

148

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

21.8

622

4026

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.7

21.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

21.7

3732

32253

Z31.5

ICD-10 Finland

Genetic counselling

1.7

21.6

494

3015

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

21.5

461

2765

D23

ICD-10 Finland

Other benign neoplasms of skin

2.3

21.5

202

890

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

21.4

603

3894

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

21.4

2894

24351

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.7

21.3

251

ZX120

NOMESCO Finland

Intravenous

1.5

21.1

818

5676

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.9

20.9

126

431

N18.0

ICD-10 Finland

End-stage renal disease

3.2

20.8

111

351

L04AA05

ATC

[U] tacrolimus; systemic

12.4

20.8

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.5

20.6

672

4487

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

12.9

20.6

D02AE01

ATC

carbamide; topical

1.6

20.5

610

3991

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

20.5

1661

13085

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.3

20.5

104

317

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

20.4

827

5791

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.0

20.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

20.1

2102

17128

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

20.1

540

3445

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.7

20.1

142

539

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

27.0

20.0

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

2.2

20.0

215

1009

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

19.9

2553

21323

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.3

19.6

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.9

19.6

285

1509

L01BB01

ATC

7.7

19.5

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

5.1

19.4

120

L03AB05

ATC

interferon alfa-2b; parenteral

5.3

19.4

112

E000001

ATC

1.3

19.3

1951

15820

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1.8

19.3

330

1847

K07.60

ICD-10 Finland

Snapping jaw

1.6

19.3

498

3143

WX402

NOMESCO Finland

General anaesthesia

1.3

19.3

1518

11901

R50.9

ICD-10 Finland

Fever, unspecified

1.4

19.2

1206

9140

S26

ICPC

Fear of cancer of skin

3.0

19.1

113

384

V03AE01

ATC

polystyrene sulfonate; oral

3.0

19.1

112

379

L01XE25

ATC

[U] trametinib; oral

18.2

19.0

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

6.7

19.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

18.9

383

2262

WX110

NOMESCO Finland

Local anesthesy

1.2

18.9

7427

69088

QBA10

NOMESCO Finland

Incision of skin of trunk

2.8

18.8

120

427

205

Kela drug reimbursment

Chronic hypertension

1.3

18.8

2029

16586

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

1.9

18.7

278

1485

D06BX01

ATC

metronidazole; topical

1.4

18.6

944

6899

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

38.4

18.5

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

18.5

313

1747

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.1

18.3

206

987

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

18.2

1817

14698

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

7.7

18.2

N63

ICD-10 Finland

Unspecified lump in breast

1.5

18.2

552

3627

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

4.4

18.2

147

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

18.1

399

2412

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.6

18.1

139

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.6

18.1

139

ICD-10 Finland

2.1

18.0

210

1018

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

32.9

17.9

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

8.7

17.8

Z94.1

ICD-10 Finland

Heart transplant status

6.3

17.8

D07AD01

ATC

clobetasol; topical

1.3

17.8

1342

10445

D06BX02

ATC

ingenol mebutate; topical

2.7

17.7

118

432

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

17.7

1341

10449

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

17.6

815

5852

D07AB08

ATC

desonide; topical

1.4

17.6

937

6904

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

95.2

17.5

UJH02

NOMESCO Finland

Anoscopy

1.7

17.4

356

2107

XKD00

NOMESCO Finland

Uroflowmetry

1.3

17.4

1126

8564

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

6.2

17.3

C08CA02

ATC

felodipine; oral

1.5

17.3

645

4436

S15

ICPC

Foreign body in skin

1.6

17.3

514

3362

C02CA01

ATC

prazosin; oral

2.7

17.2

115

422

TQW40

SPAT

1.8

17.2

273

1491

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

5.8

17.1

5AB14

NOMESCO Finland

7.4

17.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

9.7

17.1

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

16.9

2821

24179

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

16.8

295

1666

R31

ICD-10 Finland

Unspecified haematuria

1.4

16.8

710

5009

J02AC02

ATC

itraconazole; systemic

1.3

16.8

1616

12996

B35.1

ICD-10 Finland

Tinea unguium

1.6

16.8

459

2941

C02AC05

ATC

moxonidine; oral

1.7

16.8

327

1911

B01AB05

ATC

enoxaparin; parenteral

1.2

16.8

2619

22289

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

16.7

927

6875

R01AD12

ATC

fluticasone furoate; nasal

1.2

16.6

2966

25579

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

5.0

16.6

107

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.0

16.6

166

G04CA02

ATC

tamsulosin; oral

1.3

16.4

1489

11884

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

6.7

16.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

3.2

16.4

271

L01EC02

ATC

dabrafenib; oral

40.1

16.3

J01DA01

ATC

[U] cefalexin; systemic

1.2

16.2

6489

60035

JJC00

NOMESCO Finland

Allogenic transplantation of liver

6.4

16.2

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.8

16.2

175

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

12.8

16.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

16.0

886

6569

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

16.0

644

4504

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

3.9

16.0

167

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

5.0

15.8

100

Z71.8

ICD-10 Finland

Other specified counselling

1.2

15.8

2277

19194

L84

ICD-10 Finland

Corns and callosities

1.8

15.8

269

1507

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

5.0

15.7

101

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

4.7

15.7

114

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

6.7

15.7

R01AD08

ATC

fluticasone; nasal

1.2

15.6

2747

23633

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

2.9

15.6

337

R42

ICD-10 Finland

Dizziness and giddiness

1.3

15.5

1769

14524

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

15.4

4006

35713

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

15.3

820

6046

J01FF01

ATC

clindamycin; systemic

1.2

15.3

2466

21026

R06AX27

ATC

desloratadine; oral

1.2

15.3

2690

23138

JN4BD

NOMESCO Finland

Extensive body CT

1.4

15.2

838

6206

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

15.1

2155

18142

C08CA13

ATC

lercanidipine; oral

1.3

15.0

930

7028

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

6.7

14.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

14.9

424

2749

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.3

14.9

HA1AA

NOMESCO Finland

X-ray mammography

1.4

14.9

605

4242

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

6.2

14.8

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

14.7

333

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.3

14.7

134

587

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

14.7

657

4688

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

13.2

14.6

D23.4

ICD-10 Finland

Benign neoplasm: Skin of scalp and neck

2.6

14.6

108

424

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

14.6

777

5722

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

14.6

2209

18708

C07AG02

ATC

carvedilol; oral

1.6

14.5

401

2582

C43.74

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip acral

14.1

14.5

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

14.5

597

4196

Z01.7

ICD-10 Finland

Laboratory examination

1.3

14.4

923

7003

D10AX03

ATC

azelaic acid; topical

1.4

14.4

723

5268

H02AB09

ATC

hydrocortisone; systemic

1.9

14.4

202

1061

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

14.2

637

4548

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

14.2

572

4000

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

14.2

1110

8676

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.2

14.1

146

678

H02AB06

ATC

prednisolone; systemic

1.2

14.1

4388

39616

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

2.7

14.1

359

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

14.1

293

1751

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

11.9

14.0

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

14.0

6916

64694

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.7

13.9

288

1717

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

13.9

524

3614

XF404

NOMESCO Finland

Ambulatory ECG

1.4

13.9

713

5216

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

13.9

840

6320

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

13.8

1810

15077

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.3

13.8

127

556

L01EE01

ATC

trametinib; oral

53.4

13.8

4056

NOMESCO Finland

7.8

13.8

D02AX

ATC

Other emollients and protectives

1.7

13.8

288

1720

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

13.8

662

4788

SPAT1325

SPAT

Vaccination

1.2

13.8

3043

26689

QXA05

NOMESCO Finland

Skin division, unspecified location

4.3

13.7

117

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

5.1

13.7

C44

ICD-10 Finland

Other malignant neoplasms of skin

5.6

13.7

S08

ICPC

Skin colour change

1.6

13.7

382

2468

R06AE07

ATC

cetirizine; oral

1.2

13.6

4393

39758

2161A

ICD-9 Finland

Benign neoplasm of skin, Eyelid, including canthus[SILMÄLUOMEN BEN KASVAIN, NAEVUS PIGMENTOSUS]

+∞

13.5

J01FA06

ATC

roxithromycin; oral

1.2

13.5

3799

33991

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

10.0

13.4

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

13.4

3157

27832

187

Kela drug reimbursment

MPA

25.7

13.3

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.3

13.3

196

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

13.3

292

1773

C05AA08

ATC

fluocortolone; rectal, topical

1.3

13.2

1161

9218

C08CA01

ATC

amlodipine; oral

1.2

13.1

2694

23454

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

5.0

13.1

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

13.1

2010

17017

P01AB01

ATC

metronidazole; oral, rectal

1.2

13.1

3846

34509

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

2.1

13.1

144

688

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.3

13.1

1036

8110

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

13.0

1122

8890

Z01.2

ICD-10 Finland

Dental examination

1.2

12.9

4099

36990

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.3

12.9

988

7697

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

12.9

1316

10648

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

12.9

142

680

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

4.2

12.8

111

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

12.8

5175

47548

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.6

12.8

160

RS220

NOMESCO Finland

2.3

12.8

118

522

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

12.7

1265

10198

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

12.7

605

4368

QDE00

NOMESCO Finland

Excision of loose skin or fold of skin from lower limb

10.5

12.7

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

12.7

400

2658

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

9.6

12.7

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.4

12.7

103

428

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.9

12.6

169

874

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

12.6

2092

17855

R4180

NOMESCO Finland

Podiatric therapy

2.6

12.5

355

Z94.2

ICD-10 Finland

Lung transplant status

6.1

12.5

K06.18

ICD-10 Finland

Another gingival hyperplasia

4.5

12.5

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.3

12.4

110

477

K65.0

ICD-10 Finland

Acute peritonitis

2.6

12.4

351

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.2

12.3

118

531

D01BA02

ATC

terbinafine; oral; topical

1.2

12.3

2084

17813

C03CA01

ATC

furosemide; systemic

1.2

12.2

1916

16259

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

12.1

1472

12153

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

1.9

12.1

177

947

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

12.1

3847

34688

H05BX01

ATC

cinacalcet; oral

3.5

12.1

153

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

12.0

819

6273

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

12.0

1115

8911

A12BA01

ATC

potassium chloride; oral

1.7

12.0

261

1581

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

21.3

12.0

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.0

11.9

148

745

D07XC01

ATC

betamethasone, combinations; topical

1.3

11.9

934

7305

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

7.5

11.9

J01AA04

ATC

lymecycline; systemic

1.3

11.9

1227

9943

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

11.7

869

6741

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

11.7

471

3301

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.1

11.6

4522

41336

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

11.6

1077

8611

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

11.6

7555

71573

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.5

11.6

148

2169A

ICD-9 Finland

Benign neoplasm of skin, Skin, site unspecified[IHON BEN KASV,NUD,NAEVUS PIGMENTOSUS]

+∞

11.5

WW200

SPAT

0.7

11.4

540

7217

J01EA01

ATC

trimethoprim; systemic

1.2

11.4

2257

19555

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.2

11.3

183

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

11.3

1269

10380

SPAT1312

SPAT

General health counselling

1.2

11.3

3111

27710

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

8.3

11.3

WW200

NOMESCO Finland

Immunization

1.7

11.2

224

1327

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

11.2

1252

10237

C43.41

ICD-10 Finland

Malignant melanoma of the scalp and neck originating in lentigo maligna

25.0

11.1

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.5

11.1

394

2691

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.8

11.1

182

1013

M25.5

ICD-10 Finland

Pain in joint

1.2

11.1

2595

22805

TFJ02

NOMESCO Finland

Muscle biopsy of heart

4.9

11.1

JJ5AT

NOMESCO Finland

8.0

11.0

N02AX02

ATC

tramadol; systemic, rectal

1.2

11.0

3740

33823

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

11.0

866

6770

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

10.9

758

5821

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

10.9

287

1828

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

10.9

769

5921

CBA10

NOMESCO Finland

Biopsy of eyelid

2.7

10.9

257

V03AE03

ATC

lanthanum carbonate; oral

4.0

10.8

106

R03AC02

ATC

salbutamol; inhalant

1.1

10.8

5229

48445

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.7

10.8

268

L85.3

ICD-10 Finland

Xerosis cutis

2.5

10.7

344

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

10.5

10.7

C02EA02

ATC

1.6

10.7

263

1649

M79.6

ICD-10 Finland

Pain in limb

1.2

10.7

3239

29029

5602

FHL

Internal fistula (eg Cimino)

17.8

10.7

DAB10

NOMESCO Finland

Partial excision of auricle

4.1

10.7

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

10.6

10098

97952

D10BA01

ATC

isotretinoin; oral

1.4

10.6

589

4369

J01AA07

ATC

tetracycline; systemic

1.2

10.6

1414

11785

A02BC03

ATC

lansoprazole; oral

1.2

10.5

2493

21918

B02AA02

ATC

tranexamic acid; systemic

1.2

10.5

1332

11045

G01AA10

ATC

clindamycin; vaginal

1.2

10.5

1369

11387

J01FA09

ATC

clarithromycin; systemic

1.2

10.4

2973

26517

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

10.4

1092

8859

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

10.4

1851

15877

QXE15

NOMESCO Finland

Excision of other superficial lesion of skin in unspecified region

12.0

10.3

C43.80

ICD-10 Finland

Overall malignant melanoma of the skin without histology

32.5

10.3

QDE15

NOMESCO Finland

Excision of other superficial lesion of skin in lower limb

9.5

10.2

KAS40

NOMESCO Finland

Excision of transplanted kidney

23.4

10.2

E000007

ATC

1.4

10.2

480

3465

KMAK

NOMESCO Finland

1.1

10.2

5357

49833

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.0

10.2

119

585

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.4

10.2

138

R23

ICD-10 Finland

Other skin changes

2.3

10.2

406

R06.5

ICD-10 Finland

Mouth breathing

1.3

10.1

675

5156

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

10.1

703

5407

R13

ICD-10 Finland

Dysphagia

1.4

10.1

456

3271

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

10.0

2789

24819

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

10.0

423

2995

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

4.9

10.0

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

10.0

2295

20118

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

10.0

613

4628

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

10.0

417

2947

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

10.0

327

2197

E000002

ATC

1.3

9.9

991

7989

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.7

9.9

338

4754

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

3.7

9.9

110

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

3.4

9.9

136

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

9.9

3756

34178

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

3.2

9.9

152

K03.00

ICD-10 Finland

Approximal wear

1.4

9.8

401

2817

6119

FHL

Other measure in this category

26.0

9.8

L71.9

ICD-10 Finland

Rosacea, unspecified

1.8

9.8

169

959

5850B

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]

20.0

9.8

EMB10

NOMESCO Finland

Tonsillectomy

1.4

9.7

546

4062

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.1

9.7

111

541

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.5

9.7

288

1893

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

3.9

9.6

M03BX02

ATC

tizanidine; oral

1.1

9.6

6291

59234

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

9.6

314

2107

R35

ICD-10 Finland

Polyuria

1.4

9.6

426

3043

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

9.5

1690

14475

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

3.6

9.5

114

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.2

9.5

393

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.7

9.5

190

1126

L04AA10

ATC

sirolimus; oral

11.3

9.5

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

9.5

594

4492

C03DA01

ATC

spironolactone; oral

1.3

9.5

707

5490

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

9.5

4638

42874

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

15.0

9.5

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

10.0

9.5

D07AA02

ATC

hydrocortisone; topical

1.2

9.5

1219

10118

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.3

9.5

141

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

9.4

1029

8383

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.4

9.4

432

3107

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

9.4

517

3837

305

Kela drug reimbursment

MPA

+∞

9.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.4

9.4

382

2685

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

9.4

2136

18701

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

9.4

722

5634

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.5

9.4

308

2075

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

5.1

9.3

XQ800

NOMESCO Finland

Prick test

1.3

9.3

663

5112

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

12.3

9.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

9.3

771

6072

D19

ICPC

Teeth/gum symptom/complaint

1.2

9.3

2425

21456

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

8.0

9.3

H61.2

ICD-10 Finland

Impacted cerumen

1.4

9.3

412

2944

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

4.7

9.3

115

Kela drug reimbursment

Breast cancer

1.3

9.3

598

4549

C08CA05

ATC

nifedipine; systemic

1.4

9.3

439

3175

C09CA06

ATC

candesartan; oral

1.2

9.2

1724

14834

R51.80

ICD-10 Finland

Headache

1.2

9.2

1331

11179

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

9.2

958

7762

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.6

9.2

206

1264

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

4.1

9.2

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

5.7

9.2

BE00A

NOMESCO Finland

13.6

9.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

9.1

968

7862

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

9.1

347

2412

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

4.3

9.1

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

11.4

9.0

3016

Kela drug reimbursment

Binimetinib and encorafenib

15.6

9.0

Z00.0

ICD-10 Finland

General medical examination

1.2

9.0

1559

13324

C10AA03

ATC

pravastatin; oral

1.4

9.0

449

3278

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

9.0

906

7314

VALMI

NOMESCO Finland

1.2

9.0

2348

20771

C09CA01

ATC

losartan; oral

1.2

9.0

1767

15280

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.1

8.9

3480

31670

D03.30

ICD-10 Finland

Melanoma in situ on the lip

18.6

8.9

R06AE09

ATC

levocetirizine; oral

1.2

8.9

1307

10996

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

8.9

630

4858

WXQ99

NOMESCO Finland

Other light therapy

7.4

8.9

G44.2

ICD-10 Finland

Tension-type headache

1.2

8.8

1151

9567

ZX108

NOMESCO Finland

Inhalation

2.5

8.8

252

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

7.9

8.8

A02BA02

ATC

ranitidine; systemic

1.2

8.8

1496

12761

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

6.3

8.7

3AC01

NOMESCO Finland

2.1

8.7

423

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.1

8.7

2743

24591

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.7

8.7

163

951

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

3.5

8.7

113

L85.89

ICD-10 Finland

Other specified epidermal thickening

4.7

8.7

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

8.7

589

4518

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

8.7

818

6552

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

4.8

8.6

R03DC03

ATC

montelukast; oral

1.2

8.6

1388

11776

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.8

8.6

151

861

Z99.2

ICD-10 Finland

Dependence on renal dialysis

6.6

8.6

XF612

NOMESCO Finland

Measurement of central venous pressure

4.1

8.6

QCE00

NOMESCO Finland

Excision of loose skin or fold of skin from upper limb

11.5

8.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

8.6

658

5134

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

8.5

1507

12899

H26.3

ICD-10 Finland

Drug-induced cataract

2.8

8.5

181

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.0

8.5

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.3

8.5

656

5123

R06AX22

ATC

ebastine; oral

1.2

8.5

1524

13064

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.3

8.5

329

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.7

8.5

198

C43.43

ICD-10 Finland

Malignant melanoma of the scalp and neck nodular

20.0

8.5

J35.0

ICD-10 Finland

Chronic tonsillitis

1.4

8.5

481

3590

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.0

8.5

106

539

QAA10

NOMESCO Finland

Incision of skin of head or neck

4.2

8.5

-59

ICPC

Other therap proced/minor surg NEC

1.6

8.5

208

1311

J01MA06

ATC

norfloxacin; oral

1.2

8.4

1070

8869

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

8.4

733

5814

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.0

8.4

106

542

ZX197

NOMESCO Finland

5.6

8.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.1

8.4

4306

39832

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

1.8

8.4

130

713

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

4.3

8.4

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.3

8.4

862

6978

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

6.7

8.3

2162A

ICD-9 Finland

Benign neoplasm of skin, Ear and external auditory canal[KORVAN IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

8.3

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.9

8.3

172

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

8.3

617

4794

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.8

8.3

185

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

3.8

8.3

L71.8

ICD-10 Finland

Other rosacea

1.9

8.3

109

566

HAC20

NOMESCO Finland

Total mastectomy

1.5

8.3

293

2008

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

5.8

8.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

8.2

526

3998

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

2.4

8.2

290

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

8.2

320

2236

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

4.4

8.2

QDE20

NOMESCO Finland

Excision and repair of scar or web of skin of lower limb

4.4

8.2

1513

Kela drug reimbursment

Binimetinib and encorafenib

14.5

8.2

C43.4

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of scalp and neck

14.5

8.2

XX4BW

NOMESCO Finland

4.9

8.2

SBB10

NOMESCO Finland

Teeth copy

1.3

8.1

536

4091

D24

ICD-10 Finland

Benign neoplasm of breast

1.7

8.1

159

940

GDG10

NOMESCO Finland

Bilateral transplantation of lung

5.6

8.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

8.1

1535

13221

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.8

8.1

126

696

XF602

NOMESCO Finland

Bloodpressure monitoring

2.2

8.1

358

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

1.8

8.1

120

653

C43.22

ICD-10 Finland

Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type

17.2

8.1

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

17.2

8.1

H93.1

ICD-10 Finland

Tinnitus

1.3

8.1

472

3538

C44.79

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including hip or other unspecified histology

11.7

8.1

J01MA14

ATC

moxifloxacin; systemic

1.3

8.1

654

5143

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.6

8.0

184

1140

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

1.8

8.0

140

799

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.6

8.0

177

1084

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

8.0

1098

9172

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

10.0

8.0

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

8.0

2598

23326

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

8.0

550

4229

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

7.9

205

1309

A07AA02

ATC

nystatin; oral

1.4

7.9

439

3269

L90.6

ICD-10 Finland

Striae atrophicae

3.3

7.9

112

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.4

7.9

346

2472

D07AC13

ATC

mometasone; topical

1.1

7.9

2533

22727

GD1LA

NOMESCO Finland

2.1

7.9

429

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

7.9

474

3573

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

1.7

7.8

151

889

ZXC12

NOMESCO Finland

Pulse colorlaser

3.2

7.8

118

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.7

7.8

151

892

L02BA01

ATC

tamoxifen; oral

1.5

7.8

290

2005

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.4

7.8

366

2644

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

7.8

606

4738

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.3

7.8

535

4115

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

7.8

417

3087

N083, E102

ICD-10 Finland

9.4

7.8

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

1.9

7.7

105

553

602

Kela drug reimbursment

Children's severe malnutrition

4.0

7.7

H02.3

ICD-10 Finland

Blepharochalasis

1.4

7.7

419

3108

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.6

7.7

182

1134

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

3.3

7.7

114

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.6

7.7

169

1035

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

15.0

7.7

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

7.7

540

4166

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

7.7

668

5300

R05

ICD-10 Finland

Cough

1.2

7.7

1588

13781

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

7.6

468

3537

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

3.2

7.6

115

R03BA08

ATC

ciclesonide; inhalant

1.3

7.6

651

5153

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

7.6

270

1853

Z94.3

ICD-10 Finland

Heart and lungs transplant status

18.3

7.6

C07AA05

ATC

propranolol; systemic

1.2

7.6

1711

14950

8720/2-C44.5

ICD-O-3

Melanoma in situ of skin of trunk

25.0

7.6

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

11.8

7.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

7.5

302

2124

EAA10

NOMESCO Finland

Excision of lesion of lip

2.0

7.5

453

2504

FHL

Unilateral resection or enucleation

2.5

7.5

209

L60.0

ICD-10 Finland

Ingrowing nail

1.4

7.5

313

2218

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

2.9

7.5

148

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.7

7.5

261

3646

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

2.4

7.5

254

S04

ICPC

Lump/swelling localized

1.3

7.4

737

5943

K50.9

ICD-10 Finland

Crohn disease, unspecified

1.8

7.4

122

686

J01CA08

ATC

pivmecillinam; oral

1.1

7.4

3820

35280

UDC00

NOMESCO Finland

Ear microscopy

1.3

7.4

539

4176

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.4

7.4

402

2985

ZXC10

NOMESCO Finland

Use of laser

1.6

7.4

167

1030

8720/3-C44.2

ICD-O-3

Malignant melanoma, NOS, of external ear

13.3

7.4

ZZS00

NOMESCO Finland

Rotation flap

5.3

7.4

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

7.4

412

3072

D01AE15

ATC

terbinafine; topical

1.3

7.4

480

3661

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

4.5

7.4

RD210

NOMESCO Finland

1.7

7.3

141

830

RJ411

NOMESCO Finland

2.7

7.3

181

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.4

7.3

304

2153

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.4

7.3

319

2277

D31.0

ICD-10 Finland

Benign neoplasm: Conjunctiva

2.3

7.3

261

C07AB07

ATC

bisoprolol; oral

1.1

7.3

3706

34189

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.4

7.3

352

2557

D10AF01

ATC

clindamycin; topical

1.3

7.3

419

3136

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.0

7.3

430

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

9.3

7.3

N19

ICD-10 Finland

Unspecified kidney failure

1.6

7.3

184

1173

C03AA03

ATC

hydrochlorothiazide; oral

1.3

7.2

612

4845

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

5.4

7.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

7.2

7349

70404

QDH05

NOMESCO Finland

Correction of deformity of toe nail

3.4

7.2

WX704

NOMESCO Finland

Intubation

1.3

7.2

557

4357

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.4

7.1

359

2628

I49.1

ICD-10 Finland

Atrial premature depolarization

1.5

7.1

221

1473

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

20.0

7.1

C43.91

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin originating in lentigo maligna

20.0

7.1

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

7.1

521

4045

M54.2

ICD-10 Finland

Cervicalgia

1.3

7.1

541

4219

R4190

NOMESCO Finland

Nutritional therapy

1.5

7.1

243

1655

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

6.5

7.1

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

5.3

7.1

4AA09

NOMESCO Finland

10.0

7.0

G04BD12

ATC

mirabegron; oral

1.3

7.0

667

5357

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.5

7.0

938

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.6

7.0

171

1078

C07AB02

ATC

metoprolol; systemic

1.2

7.0

1429

12385

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

4.1

7.0

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

7.0

687

5537

R4120

NOMESCO Finland

Occupational therapy

1.3

6.9

459

3514

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.6

6.9

156

964

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

3.7

6.9

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

6.9

985

8264

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

1.9

6.9

484

N64.4

ICD-10 Finland

Mastodynia

1.5

6.9

218

1462

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

6.9

630

5035

C01CA24

ATC

epinephrine; parenteral

1.3

6.9

519

4047

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

6.9

690

5577

QDA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of lower limb

4.0

6.9

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.2

6.8

744

6067

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

6.8

466

3583

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.2

6.8

735

5986

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

8.2

6.8

C10AA05

ATC

atorvastatin; oral

1.1

6.8

2814

25634

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.4

6.8

317

2293

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

2.8

6.8

149

A07EC02

ATC

mesalazine; oral, rectal

1.3

6.8

417

3156

G03DB01

ATC

dydrogesterone; oral

1.2

6.8

1179

10075

L72.0

ICD-10 Finland

Epidermal cyst

2.0

6.8

402

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

1.8

6.8

114

648

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

6.7

326

2372

QDA50

NOMESCO Finland

Cryotherapy of skin of lower limb

4.0

6.7

S80

ICPC

Solar keratosis/sunburn

3.8

6.7

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

2.9

6.7

127

H3603, E103

ICD-10 Finland

1.9

6.7

445

QAA25

SPAT

4.3

6.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

6.7

841

6966

RS321

NOMESCO Finland

7.1

6.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.5

6.7

225

1532

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

1.5

6.7

193

1269

C43.92

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type

22.5

6.7

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.6

6.6

180

1167

QBE10

SPAT

3.1

6.6

106

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.3

6.6

642

5167

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.0

6.6

364

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

6.6

245

1700

XW000

NOMESCO Finland

Bone marrow biopsy

1.4

6.6

255

1785

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

3.2

6.5

M05BA04

ATC

alendronic acid; oral

1.3

6.5

485

3776

H26.2

ICD-10 Finland

Complicated cataract

1.9

6.5

459

M04AA01

ATC

allopurinol; systemic

1.2

6.5

764

6285

M01AE03

ATC

ketoprofen; systemic, rectal

1.1

6.5

3238

29809

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.5

6.5

1034

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.5

755

6205

N05CF02

ATC

zolpidem; oral

1.2

6.5

1468

12829

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.1

6.5

5320

50280

WZA90

NOMESCO Finland

Other doctors statement

1.1

6.5

2063

18475

R30.0

ICD-10 Finland

Dysuria

1.4

6.4

258

1818

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

6.4

1335

11580

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.4

6.4

346

2568

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

5.7

6.4

QAE99

SPAT

2.5

6.4

191

D03.8

ICD-10 Finland

Melanoma in situ of other sites

69.9

6.4

7155

FHL

Exploration of the graft

69.9

6.4

L73.8

ICD-10 Finland

Other specified follicular disorders

2.1

6.4

326

M10.3

ICD-10 Finland

Gout due to impairment of renal function

3.1

6.4

103

S79

ICPC

Neoplasm skin benign/unspecified

1.7

6.4

127

761

C43.20

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal without histology

14.3

6.4

J01DA08

ATC

[U] cefaclor; oral

1.2

6.4

1054

8965

RJ210

NOMESCO Finland

3.4

6.4

RJ420

NOMESCO Finland

2.8

6.4

137

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

6.3

241

1682

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

2.6

6.3

161

58209

ICD-8 Finland

Chronic nephritis, Unspecified

4.9

6.3

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

4.4

6.3

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

4.4

6.3

H26.4

ICD-10 Finland

After-cataract

1.3

6.3

515

4059

L17

ICPC

Foot/toe symptom/complaint

1.1

6.3

2097

18829

R06AX13

ATC

loratadine; oral

1.2

6.3

1359

11824

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

5.1

6.3

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

5.1

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

11.0

6.3

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

6.3

334

2473

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

6.3

418

3206

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

9.2

6.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.7

6.3

110

636

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

3.5

6.3

A07AA09

ATC

vancomycin; oral

1.9

6.3

438

8721/3-C44.9

ICD-O-3

Nodular melanoma of skin, NOS

18.0

6.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.6

6.2

160

1022

C43.81

ICD-10 Finland

Overall malignant melanoma of the skin originating in lentigo maligna

+∞

6.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.2

1428

12486

PJA10

NOMESCO Finland

Exploration of lymph nodes

1.9

6.2

439

R01AD11

ATC

triamcinolone; nasal

1.2

6.2

709

5811

WX400

NOMESCO Finland

Inhalation anesthesy

1.4

6.2

344

2566

D03.2

ICD-10 Finland

Melanoma in situ of ear and external auricular canal

26.7

6.2

8742/3-C44.5

ICD-O-3

Lentigo maligna melanoma of skin of trunk

26.7

6.2

L01XE15

ATC

[U] vemurafenib; oral

26.7

6.2

8721/3-C44.5

ICD-O-3

Nodular melanoma of skin of trunk

26.7

6.2

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

2.9

6.2

126

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

4.3

6.2

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

6.2

172

1122

R04.0

ICD-10 Finland

Epistaxis

1.3

6.2

442

3421

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

3.4

6.2

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.4

6.2

281

2030

Q82.50

ICD-10 Finland

Naevus flammeus

3.9

6.2

B08.1

ICD-10 Finland

Molluscum contagiosum

3.2

6.2

TAKUU

NOMESCO Finland

2.0

6.1

355

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.1

6.1

319

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

5.3

6.1

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

1.7

6.1

119

708

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

1.8

6.1

493

J20

ICD-10 Finland

Acute bronchitis

1.2

6.1

722

5947

H92.0

ICD-10 Finland

Otalgia

1.3

6.1

388

2957

N64.9

ICD-10 Finland

Disorder of breast, unspecified

1.9

6.1

411

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.4

6.1

249

1762

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

2.8

6.1

129

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.3

6.1

389

2963

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

6.1

1019

8676

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

6.1

351

2632

A10AA01

ATC

1.5

6.1

200

1357

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.3

6.1

376

2853

XF402

NOMESCO Finland

ECG with work load test

1.2

6.1

756

6257

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

1.6

6.1

129

788

5829A

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]

12.5

6.1

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.7

6.1

127

770

K30

ICD-10 Finland

Functional dyspepsia

1.2

6.1

810

6756

RJ120

NOMESCO Finland

4.0

6.1

L03AB04

ATC

interferon alfa-2a; parenteral

4.0

6.1

K50.8

ICD-10 Finland

Other Crohn disease

1.7

6.1

122

734

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

2.5

6.1

178

K65.9

ICD-10 Finland

Peritonitis, unspecified

3.6

6.1

B02.9

ICD-10 Finland

Zoster without complication

1.3

6.1

353

2654

C07AB03

ATC

atenolol; systemic

1.3

6.1

345

2583

DHB50

NOMESCO Finland

Turbinoplasty

1.5

6.1

189

1269

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.4

6.1

240

1691

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

6.0

917

7743

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.0

410

3156

J01MA12

ATC

levofloxacin; systemic

1.2

6.0

1374

12009

C10AA04

ATC

fluvastatin; oral

1.3

6.0

518

4114

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

7779

45966

2.60

307.65

2.9

2.0

—

(3002256) Pathology report gross observation

3155

14261

2.57

307.65

1.6

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

281

441

6.48

170.36

29.0

24.8

97.5

114.8

ug/l

4.15

239

363

(40768443) Skin Pathology biopsy report

1096

4766

2.41

149.11

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

248

442

5.70

132.09

40.6

34.2

6.9

7.4

ug/l

3.87

220

408

(3019420) Tryptase [Mass/volume] in Serum or Plasma

274

603

4.62

114.61

1.3

1.5

7.0

7.7

ug/l

0.25

258

536

(3001604) Monocytes [#/volume] in Blood

6972

56535

1.47

103.87

7.4

5.8

0.6

e9/l

2.24

6167

49067

(3006315) Basophils [#/volume] in Blood

6991

56780

1.47

102.90

7.4

5.8

0.0

e9/l

1.27

6188

49256

(3019198) Lymphocytes [#/volume] in Blood

7154

58432

1.47

101.84

7.4

5.8

2.0

1.9

e9/l

0.15

6448

51685

(3013115) Eosinophils [#/volume] in Blood

7173

58753

1.46

99.73

7.6

6.0

0.2

e9/l

2.12

6424

51829

(3013650) Neutrophils [#/volume] in Blood by Automated count

7820

65359

1.46

96.19

10.4

8.9

3.9

4.1

e9/l

9.31

6935

57174

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

141

213

6.68

88.69

1.0

2.0

1.6

3.8

ug/l

0.95

123

(4035726)

1554

9284

1.76

85.72

1.5

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

10711

96783

1.48

75.89

19.1

15.6

13.6

2.20

10550

94848

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9551

85028

1.40

68.68

9.2

7.3

75.5

76.8

u/l

1.99

9086

80167

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5677

46631

1.37

66.53

2.5

2.2

77.8

2006.4

nmol/l

0.50

5257

42482

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

500

2184

2.34

66.40

8.5

5.3

1458.0

1871.3

iu/ml

0.15

297

(3024561) Albumin [Mass/volume] in Serum or Plasma

5614

46063

1.37

66.11

6.1

4.7

36.4

35.8

g/l

11.66

5288

42837

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1249

7607

1.71

63.29

5.7

3.8

102.8

87.8

ng/l

4.77

1140

6590

(3019069) Monocytes/100 leukocytes in Blood

6345

53464

1.35

61.17

7.8

6.3

8.4

0.09

6028

50126

(3006504) Eosinophils/100 leukocytes in Blood

6311

53170

1.35

60.73

7.6

6.0

2.9

2.8

0.13

5950

49566

(3002030) Lymphocytes/100 leukocytes in Blood

6521

55214

1.34

60.67

7.6

6.0

28.9

28.5

2.31

6174

51521

(3022096) Basophils/100 leukocytes in Blood

6130

51482

1.34

59.96

7.7

6.0

0.7

0.16

5790

48005

(3018010) Neutrophils/100 leukocytes in Blood

6431

54430

1.34

59.56

7.4

5.8

56.6

56.9

1.29

6094

50991

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6235

52535

1.34

59.49

8.8

6.4

1.2

mmol/l

0.36

5386

44378

(3013707) Erythrocyte sedimentation rate by Westergren method

9345

83720

1.36

58.73

4.6

3.9

10.6

11.3

mm/h

6.07

8761

77918

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12219

114985

1.57

57.18

15.7

13.0

21.4

22.5

mg/l

2.93

9595

90229

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12749

121368

1.70

55.08

12.0

9.8

25.4

26.2

u/l

3.58

12434

117404

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6594

56440

1.32

54.57

7.1

5.9

11.0

umol/l

0.01

6263

53430

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

391

1672

2.38

54.48

4.4

2.6

432.3

2239.0

u/ml

1.48

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11391

105886

1.44

54.43

5.3

4.7

1.8

2.0

mu/l

3.06

10740

98145

(3019550) Sodium [Moles/volume] in Serum or Plasma

12193

114949

1.54

53.63

17.4

14.4

139.7

139.6

mmol/l

2.37

11967

112034

(3018095) Leukocytes [#/volume] in Urine

4759

38973

1.34

53.10

4.6

3.5

64.2

91.9

e6/l

1.69

3437

26945

(3035941) MCH [Entitic mass]

13304

128487

2.12

52.49

23.2

19.0

30.2

0.51

13200

126930

(3026361) Erythrocytes [#/volume] in Blood

13305

128511

2.12

52.30

23.3

19.1

4.5

e12/l

0.30

13054

125234

(40761511) CBC panel - Blood by Automated count

12634

120196

1.64

52.13

14.3

12.1

—

(3024731) MCV [Entitic volume]

13303

128500

2.11

52.03

23.2

19.0

90.6

90.7

1.24

13200

126942

(3010813) Leukocytes [#/volume] in Blood

13306

128544

2.11

51.95

23.4

19.1

6.6

6.7

e9/l

5.91

13048

125217

(3000963) Hemoglobin [Mass/volume] in Blood

13306

128548

2.11

51.88

23.4

19.2

135.0

135.2

g/l

0.70

13200

126990

(40760892) CBC W Ordered Manual Differential panel - Blood

3350

26078

1.38

51.68

5.3

4.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

12209

115283

1.53

51.64

17.7

14.5

3.9

mmol/l

4.49

11970

112121

(3007461) Platelets [#/volume] in Blood

13293

128397

2.09

51.53

23.3

19.1

253.9

255.8

e9/l

2.96

13073

125426

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1904

13404

1.49

51.32

9.9

5.7

1.1

1.0

mmol/l

3.21

1805

12518

(3044889) 12 lead EKG panel

8497

75727

1.32

50.97

3.9

3.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1677

11518

1.52

50.91

5.8

4.1

235.6

239.3

u/l

0.40

1609

10880

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2449

18160

1.42

50.08

3.1

2.7

1.1

1.3

e6/l

0.26

1495

10227

(42870588) Differential panel, method unspecified - Blood

4635

38055

1.33

49.99

7.4

5.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

5.72

49.30

5.3

5.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1337

8811

1.57

48.83

13.4

7.2

10.1

9.3

mmol/l

4.07

1287

8415

(3037467) Urinalysis macro (dipstick) panel - Urine

8759

78631

1.31

48.49

5.0

4.2

—

(3033658) Prothrombin time (PT) actual/Normal

3502

27778

1.35

47.10

4.7

3.8

92.4

92.0

0.51

3417

27048

(3030467) Casts [#/volume] in Urine by Automated count

3728

29885

1.34

46.62

3.8

3.0

0.3

0.4

e6/l

2.59

2859

22264

(3018418) pH of Serum or Plasma

3861

31112

1.34

46.61

5.9

3.9

7.4

1.87

607

5994

(3002582) Erythrocytes [#/volume] in Urine

4026

32647

1.33

46.51

4.1

3.1

56.4

80.9

e6/l

0.82

3173

24821

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9849

90093

1.33

46.43

4.5

4.0

14.7

14.6

pmol/l

0.78

9160

82726

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11961

112992

1.45

45.11

5.0

4.5

2.8

mmol/l

6.93

11273

105044

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11807

111328

1.43

44.44

4.6

4.1

4.7

mmol/l

4.29

11193

104133

(3003338) MCHC [Mass/volume]

10751

99852

1.35

44.11

20.2

16.3

332.6

332.5

g/l

0.33

10688

99136

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5568

47494

1.29

43.45

7.8

5.7

1.2

mmol/l

0.54

5126

43141

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

540

2855

1.93

43.44

6.4

3.5

1.6

1.5

mg/l

4.49

514

2639

(3021589) Normoblasts [#/volume] in Blood

5836

50132

1.29

42.90

10.8

9.1

0.0

e9/l

1.95

4785

41011

(3031040) Bacteria [#/volume] in Urine by Automated count

8365

75222

1.29

42.47

4.8

4.2

652.6

1770.7

e6/l

2.79

113

958

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11722

110561

1.41

42.41

4.5

4.1

1.5

mmol/l

5.27

11054

103001

(3009261) Glucose [Presence] in Urine by Test strip

6508

56731

1.28

42.34

4.1

3.5

0.0

estimate

3.56

1123

10624

(3021601) Nitrite [Presence] in Urine by Test strip

6447

56195

1.28

41.72

5.5

4.7

0.0

estimate

2.81

1153

10903

(3007853) Bacteria identified in Skin by Aerobe culture

1820

13207

1.44

41.15

1.9

1.7

—

(36304419) Bacteria [Presence] in Urine

3624

29369

1.32

40.92

3.7

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4486

37420

1.30

40.86

3.8

3.2

29.2

33.3

u/l

6.65

4280

35504

(3035350) Ketones [Presence] in Urine by Test strip

6413

56014

1.27

40.21

4.1

3.5

0.0

estimate

1.54

1120

10613

(3000850) Epithelial cells [#/volume] in Urine

2883

22668

1.34

39.99

3.3

2.5

4.3

6.2

e6/l

13.44

2543

19777

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11485

108237

1.37

39.32

4.6

4.2

5.8

mmol/l

4.40

10761

99723

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11338

106703

1.36

38.61

4.1

3.7

1.2

1.3

mmol/l

8.97

10626

98870

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

395

3.42

37.57

2.8

2.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2220

16919

1.37

37.37

3.4

2.8

2.7

3.0

e6/l

1.09

1273

9021

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6088

53139

1.26

37.29

3.4

2.9

108.3

110.5

ug/l

0.24

5778

49655

(3015377) Calcium [Moles/volume] in Serum or Plasma

4304

36082

1.28

36.67

4.0

3.3

2.4

mmol/l

0.19

3807

31700

(3000494) Fungus identified in Specimen by Culture

1762

12971

1.41

36.42

1.6

1.4

—

(3042733) HLA Ab [Presence] in Serum

119

332

3.61

36.30

5.7

4.8

—

(40758558) Short blood count panel - Blood

3461

28292

1.30

35.70

8.3

6.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5018

43048

1.26

34.84

2.0

1.9

97.4

96.6

pmol/l

0.60

2565

22715

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8898

81507

1.26

34.53

3.5

3.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2505

19758

1.33

33.15

3.7

3.5

387.0

477.8

ng/l

0.46

1787

14216

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10724

100863

1.29

31.36

5.8

5.3

38.6

39.1

mmol/mol

5.97

10130

94026

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2188

17055

1.34

31.21

4.8

3.3

0.8

mmol/l

0.55

2045

15960

(3026493) Urate [Moles/volume] in Serum or Plasma

3404

28174

1.28

31.03

3.2

2.5

4031.6

3805.4

umol/l

0.12

3028

24625

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

601

3646

1.68

30.43

2.0

1.7

1.2

g/l

1.79

573

3476

(3005322) IgE [Units/volume] in Serum or Plasma

1102

7695

1.47

30.04

1.3

180.5

225.0

u/ml

1.00

1038

7099

(3011397) Hemoglobin [Presence] in Urine by Test strip

3170

26181

1.27

29.07

4.1

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6101

54195

1.23

28.94

4.2

3.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7089

63952

1.22

28.87

5.3

4.5

6.5

6.6

mmol/l

3.68

6587

59075

(3026782) Osmolality of Urine

2592

20950

1.29

28.08

3.7

2.7

523.2

544.3

mosm/kgh2o

0.65

2244

17789

(3014576) Chloride [Moles/volume] in Serum or Plasma

1645

12482

1.36

27.77

7.4

7.1

104.5

mmol/l

0.07

1624

12223

(3009542) Hematocrit [Volume Fraction] of Blood

11281

107230

1.29

27.52

16.8

13.8

40.0

39.9

0.98

8565

80943

(40768446) Kidney Pathology biopsy report

122

416

2.95

26.97

2.1

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1979

15530

1.32

26.53

3.5

2.4

2.3

2.4

g/l

1.76

1891

14379

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2743

22491

1.27

26.28

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2127

16905

1.31

25.94

3.4

2.4

22.9

13.4

umol/l

0.50

2029

15669

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1646

12625

1.35

25.77

3.5

2.6

6.9

7.8

umol/l

1.41

1441

10848

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2335

18814

1.29

25.63

3.3

2.9

2.4

mmol/l

4.00

2035

16413

(42529406) Shigella sp [Presence] in Stool by Culture

543

3362

1.64

25.41

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11156

106169

1.27

25.12

14.4

11.8

83.4

84.9

ml/min/173m2

10.85

9231

87244

(3022145) Colonoscopy Study observation

1600

12286

1.34

24.80

1.4

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

539

3353

1.63

24.75

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

535

3322

1.64

24.75

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

804

5483

1.50

24.58

3.7

2.6

0.2

0.3

e6/l

0.80

775

5315

(3017143) Hepatitis C virus Ab [Presence] in Serum

1921

15159

1.31

24.58

1.9

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3686

31473

1.23

24.43

2.2

2.1

163.8

202.2

u/l

3.54

3472

29563

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4010

34566

1.23

24.22

3.2

2.5

58.4

57.6

u/l

0.32

3706

31951

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.02

24.14

5.0

3.6

2.4

2.6

mg/l

0.28

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

149

4.18

23.44

6.4

5.2

48.9

41.6

ug/min

0.38

106

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

388

2250

1.75

23.21

1.8

1.4

111.8

114.2

u/ml

0.21

483

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1822

14381

1.31

23.17

3.6

2.5

23.2

23.0

0.29

1591

12283

(3002032) Base excess in Venous blood by calculation

1219

9074

1.38

23.01

5.6

4.0

1.6

1.9

mmol/l

3.30

1004

7346

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

698

4688

1.52

22.96

1.3

250.8

226.9

miu/ml

0.95

358

2238

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

413

2453

1.70

22.68

1.8

1.4

10.8

23.2

u/ml

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1219

9107

1.37

22.48

5.5

4.0

5.8

kpa

0.32

1178

8825

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

412

2460

1.70

22.19

1.9

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4923

43585

1.20

22.06

4.3

3.6

—

(3000991) Gas panel - Venous blood

1136

8438

1.38

21.69

9.0

8.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1355

10349

1.34

21.63

2.8

2.5

34.2

42.6

u/l

1.04

1171

8850

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1389

10648

1.34

21.62

2.9

2.1

369.5

375.7

nmol/l

0.62

1295

9788

(3026008) Bacteria identified in Urine by Culture

3793

32827

1.21

21.42

3.1

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2632

21930

1.25

21.38

4.6

4.2

22.8

21.8

2.42

1299

10470

(3048689) Calprotectin [Mass/mass] in Stool

1904

15271

1.29

21.29

2.6

2.4

107.7

126.0

ug/g

1.87

1521

11966

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1440

11135

1.33

21.10

1.8

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

254

1338

1.92

20.82

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2964

25094

1.23

20.67

2.1

1.7

1.2

1.1

mg/l

0.17

2235

18873

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

689

4718

1.48

20.63

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

2904

24541

1.23

20.60

4.5

3.8

1.0

kg/l

0.10

345

3714

(3032080) INR in Blood by Coagulation assay

4676

41398

1.20

20.53

8.9

8.1

1.2

inr

0.98

1283

12337

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1429

11082

1.32

20.49

1.8

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

266

1434

1.87

20.32

2.6

2.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3214

27539

1.22

19.79

5.3

4.8

2.5

3.1

ug/l

1.08

2911

24718

(3017446) Testosterone [Moles/volume] in Serum or Plasma

990

7310

1.38

19.56

2.2

2.1

12.0

11.8

nmol/l

0.50

896

6443

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3317

28563

1.21

19.34

1.7

1.6

1.3

1.4

mmol/l

1.16

2912

24253

(3024354) Oxygen [Partial pressure] in Venous blood

1002

7437

1.37

19.17

4.5

3.4

4.8

4.6

kpa

2.48

964

7184

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1960

15981

1.26

18.99

2.6

2.1

29.7

0.00

1898

15481

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1145

8696

1.35

18.89

2.8

2.5

62.5

69.5

ml/min/173m2

6.30

495

3367

(46235355) HIV 1 and 2 tests - Meaningful Use set

3091

26526

1.21

18.54

2.1

1.9

—

(40768797) Stomach Pathology biopsy report

1859

15138

1.26

18.15

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

382

2364

1.63

18.00

1.5

1.2

264.0

267.1

u/ml

0.07

263

1494

(40761535) Cells panel - Urine sediment

1130

8644

1.33

17.73

4.6

3.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1252

9722

1.32

17.68

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

646

4506

1.46

17.61

2.1

1.7

1.4

1.5

g/l

4.60

568

3871

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2914

24971

1.21

17.60

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

508

3379

1.52

17.53

3.3

2.6

3.5

3.6

g/l

0.72

481

3191

(3005719) IgG [Mass/volume] in Serum or Plasma

1117

8573

1.33

17.12

3.0

2.6

10.3

10.5

g/l

1.07

1044

7849

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1019

7723

1.35

17.01

3.4

3.3

4.5

pmol/l

0.31

936

6886

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

397

2516

1.60

16.98

1.5

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1008

7646

1.34

16.73

1.6

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

798

5838

1.39

16.65

4.2

3.4

128.1

129.8

g/l

1.29

778

5697

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2594

22086

1.22

16.61

1.8

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

678

4825

1.43

16.60

6.1

4.3

23.9

24.2

mmol/l

2.01

618

4327

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

494

3320

1.51

16.25

3.7

2.5

180.8

184.6

0.42

473

3138

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3141

27289

1.20

16.16

1.3

1.2

1.8

u/ml

3.30

859

7497

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3169

27580

1.19

15.96

2.4

2.2

2.7

2.9

mg/l

3.19

2773

23678

(3035637) Corticotropin [Mass/volume] in Plasma

252

1442

1.76

15.93

1.5

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1904

15765

1.24

15.90

3.2

3.0

0.7

0.8

ug/l

0.57

1292

10380

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

285

1693

1.70

15.77

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

523

3583

1.48

15.67

2.8

2.2

93.0

92.6

0.13

492

3323

(3042936) Bacteria identified in Isolate by Culture

1837

15178

1.24

15.62

2.2

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

6.01

15.55

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

590

4146

1.44

15.49

1.5

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

519

3561

1.48

15.43

2.2

1.7

0.2

g/l

2.76

490

3389

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1580

12861

1.26

15.32

8.2

6.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1186

9331

1.30

15.14

7.4

8.1

120.7

121.6

g/l

0.77

1137

8981

(3028026) IgM [Mass/volume] in Serum or Plasma

880

6640

1.35

15.12

2.1

1.8

1.4

1.3

g/l

0.45

817

6082

(3025941) Bacteria identified in Stool by Culture

902

6833

1.34

15.09

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1092

8503

1.31

15.06

1.9

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2740

23658

1.20

14.92

1.7

1.4

2.2

2.3

g/l

2.80

1732

14649

(3037522) Nuclear Ab [Titer] in Serum

1950

16342

1.23

14.42

1.4

524.8

538.1

titre

0.10

393

3347

(44806118)

204

1131

1.82

14.40

1.8

1.5

—

(44790048)

204

1131

1.82

14.40

1.8

1.5

—

(44790047)

204

1131

1.82

14.40

1.8

1.5

—

(44790049)

204

1131

1.82

14.40

1.8

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1377

11111

1.27

14.35

3.3

2.5

1.7

1.8

1.82

1265

9842

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

128

3.60

14.32

2.8

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

232

1339

1.75

14.29

1.7

1.5

—

(3003396) Base excess in Arterial blood by calculation

1397

11303

1.26

14.22

6.8

7.2

0.8

1.0

mmol/l

0.70

1077

8773

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

611

4390

1.41

14.20

3.7

2.9

0.6

0.7

0.35

587

4206

(21494815) CD4 cells/100 lymphocytes in Specimen

181

971

1.88

14.19

2.1

2.3

41.7

42.9

0.10

142

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1968

16543

1.22

14.10

1.9

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

4012

35915

1.17

14.03

2.5

2.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3074

26978

1.18

13.72

3.2

2.9

1427.5

1254.4

ng/l

0.92

2624

22919

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1394

11326

1.26

13.67

6.8

7.2

5.1

kpa

0.14

1327

10811

(3027801) Oxygen [Partial pressure] in Arterial blood

1393

11323

1.26

13.61

6.8

7.2

12.9

12.7

kpa

0.90

1326

10798

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1335

10828

1.26

13.28

2.0

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

633

4636

1.38

13.15

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1024

8064

1.29

12.95

2.4

2.3

28.7

24.5

au/ml

0.45

514

(3016502) Oxygen saturation in Arterial blood

1245

10071

1.26

12.66

7.2

7.7

96.2

95.7

1.84

1194

9677

(3014111) Lactate [Moles/volume] in Serum or Plasma

1102

8788

1.28

12.62

7.0

1.3

mmol/l

0.87

1066

8467

(3009214) Lutropin [Units/volume] in Serum or Plasma

543

3905

1.41

12.58

1.4

10.2

10.1

u/l

0.02

439

3196

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

353

2336

1.52

12.58

1.7

—

(3036489) Thrombin time

583

4250

1.39

12.47

2.7

2.1

21.8

21.3

0.97

515

3647

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

311

2006

1.56

12.45

5.3

2.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2727

23865

1.18

12.42

1.6

1.5

21.5

20.4

nmol/l

2.60

2409

20577

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.80

12.24

3.4

3.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

658

4920

1.35

12.02

1.1

4.1

2.2

u/ml

0.30

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.84

11.78

3.2

—

(3024928) Oxygen saturation in Venous blood

311

2034

1.54

11.73

3.6

3.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

153

829

1.86

11.72

2.4

2.2

—

(3023368) Bacteria identified in Blood by Culture

3100

27523

1.16

11.67

4.6

4.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

938

7411

1.29

11.56

1.3

59.9

47.8

au/ml

0.46

310

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

356

2404

1.49

11.56

1.7

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

451

3191

1.43

11.49

3.3

3.2

0.3

u/ml

1.90

259

1793

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

453

3208

1.43

11.48

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

710

5412

1.33

11.41

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

1025

8205

1.27

11.37

2.9

2.5

67.8

70.3

e9/l

1.41

746

6169

(3049717) Cytology report of Urine Cyto stain

485

3491

1.40

11.22

2.3

2.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

279

1801

1.56

11.18

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

483

3478

1.40

11.15

1.4

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

136

722

1.89

11.13

2.1

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

3372

30215

1.15

11.12

4.8

3.9

0.0

estimate

0.36

1117

10569

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1005

8051

1.27

11.08

3.1

2.8

164.5

178.0

ng/l

0.64

935

7291

(3016750) Collection duration of Urine

112

558

2.02

11.02

3.0

2.1

510.4

496.8

min

0.83

433

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

460

2.12

10.90

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

566

4201

1.36

10.87

1.8

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

705

5410

1.32

10.82

7.9

9.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8228

78171

1.13

10.82

3.3

3.0

42.4

44.0

u/l

0.99

7792

73484

(3014148) Varicella zoster virus Ab [Titer] in Serum

266

1713

1.56

10.79

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3424

30775

1.15

10.76

4.7

4.0

12.4

9.6

mg/mmol

1.88

2236

19490

(3009508) Creatinine [Moles/volume] in Urine

3634

32805

1.15

10.72

3.8

3.2

7.4

7.7

mmol/l

3.26

3183

27752

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

142

776

1.84

10.63

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

186

1103

1.70

10.53

1.8

1.6

—

(3024932) HLA-DR beta [Type]

339

2.28

10.40

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

390

2.19

10.40

2.8

2.0

60.5

63.4

ug/l

0.11

378

(3012516) Albumin [Mass/volume] in Urine

3268

29344

1.15

10.34

3.9

3.3

499.6

430.7

mg/l

0.32

2147

18509

(3024471) HLA-A [Type]

347

2.25

10.29

1.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

613

4648

1.33

10.25

1.7

1.6

7.8

14.6

u/ml

1.75

136

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

146

815

1.80

10.22

2.6

2.8

767.8

742.9

e6/l

0.13

349

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

500

2.03

10.15

1.2

1.1

3.2

3.8

iu/ml

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

155

883

1.76

10.14

2.2

12.7

13.6

0.38

423

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

481

2.04

10.09

1.3

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

157

900

1.75

10.05

2.2

74.1

73.5

0.18

150

862

(3004716) Salmonella sp identified in Stool by Organism specific culture

834

6611

1.28

10.03

1.4

—

(40768793) Breast Pathology biopsy report

372

2610

1.44

9.98

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3452

31191

1.14

9.90

3.6

3.1

—

(3011412) CD3 cells [#/volume] in Blood

186

1123

1.67

9.87

2.4

2.5

1.1

1.2

e9/l

0.45

117

653

(3027273) Bicarbonate [Moles/volume] in Venous blood

606

4617

1.33

9.81

4.7

3.4

25.1

25.2

mmol/l

0.36

585

4466

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.37

9.77

5.1

4.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

994

8070

1.25

9.77

2.8

2.5

66.4

66.6

g/l

0.42

927

7361

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

402

2878

1.41

9.65

1.4

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

256

1682

1.53

9.55

3.4

3.3

66.5

64.1

0.94

256

1676

(3017181) Myelocytes/100 leukocytes in Blood

1125

9299

1.23

9.37

4.9

4.1

0.9

0.07

319

2499

(3001964) Herpes simplex virus Ag [Presence] in Specimen

325

2.22

9.22

2.0

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

353

2.16

9.08

2.6

2.4

568.3

236.2

e6/l

0.37

186

(1761482) Bacteria [#/volume] in Urine by Culture

346

2443

1.43

9.01

4.4

4.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

114

617

1.85

8.89

3.3

2.7

42.2

39.8

0.39

217

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

406

2955

1.39

8.88

1.5

1.4

7.6

13.5

iu/ml

0.96

(3021440) Promyelocytes/100 leukocytes in Blood

1073

8877

1.23

8.87

5.1

4.1

0.1

0.75

295

2329

(4010399)

954

7809

1.24

8.72

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

944

7721

1.24

8.69

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

558

4279

1.32

8.67

4.9

3.9

51.1

48.8

1.33

552

4227

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

178

1103

1.62

8.59

1.6

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

131

2.91

8.51

15.3

10.6

5.5

mmol/l

0.00

131

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

375

2717

1.39

8.45

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

353

2537

1.40

8.35

2.4

2.2

0.0

g/l

0.00

332

2336

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1183

9943

1.21

8.34

2.6

2.3

0.2

g/l

4.88

1123

9246

(3002179) Metamyelocytes/100 leukocytes in Blood

1023

8484

1.22

8.26

4.6

3.9

0.5

0.6

0.82

213

1839

(3025159) Blasts/100 leukocytes in Blood

1015

8411

1.22

8.26

5.1

4.1

0.0

0.3

2.12

248

1983

(3029634) Reagin Ab [Titer] in Serum by VDRL

255

1731

1.48

8.21

2.5

1.9

2.0

6.1

titre

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

607

4749

1.29

8.15

1.9

2.0

38.3

39.4

u/l

0.83

539

4261

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

106

578

1.84

8.11

5.1

1.6

129.3

139.5

0.59

101

537

(3037692) Legionella sp identified in Specimen by Organism specific culture

330

2.13

8.10

2.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

1000

1.63

7.98

1.6

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

867

7105

1.24

7.86

1.4

1.3

24.6

27.2

iu/l

1.61

762

6124

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

124

720

1.73

7.71

7.3

6.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

354

2582

1.38

7.70

2.4

2.2

0.0

g/l

0.29

332

2345

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

379

2796

1.37

7.69

2.3

2.1

0.0

g/l

0.16

357

2550

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

3694

1.32

7.57

2.2

3.7

3.8

g/l

0.26

364

2652

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

3699

1.31

7.50

2.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2996

27238

1.13

7.48

2.5

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

3703

1.31

7.45

2.2

7.1

7.4

g/l

2.50

369

2784

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.66

7.44

4.1

2.2

—

(3011985) Renin [Units/volume] in Plasma

226

1529

1.49

7.44

1.6

1.5

34.0

60.1

mu/l

5.09

203

1369

(3004775) Volume in Urine collected for unspecified duration

130

773

1.69

7.43

3.0

2.3

727.4

637.1

1.71

103

542

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

797

6514

1.24

7.42

2.4

2.2

6143.1

5929.3

u/l

0.06

346

2613

(3022493) Free Hemoglobin [Mass/volume] in Plasma

418

1.94

7.37

6.7

3.9

149.6

926.4

mg/l

0.67

296

(3011648) Oxygen content in Venous blood

131

784

1.68

7.32

2.6

2.7

11.6

11.1

0.68

131

784

(3021387) Prolactin [Units/volume] in Serum or Plasma

655

5261

1.26

7.14

1.7

1.6

293.7

310.5

mu/l

0.77

613

4719

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

115

672

1.72

7.03

3.1

2.1

98.1

97.2

0.12

108

614

(3015171) Extractable nuclear Ab [Units/volume] in Serum

605

4824

1.27

7.02

1.3

1.0

u/ml

0.03

439

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

146

909

1.61

7.01

3.8

—

(40757373) Influenza virus identified in Isolate

194

2.38

6.99

2.2

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

177

1155

1.54

6.95

5.7

4.5

201.5

88.9

u/ml

0.66

359

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

448

3444

1.31

6.92

2.2

9.9

10.3

g/l

1.17

396

2894

(3008152) Bicarbonate [Moles/volume] in Arterial blood

754

6176

1.23

6.90

7.4

7.0

24.4

24.5

mmol/l

0.22

703

5735

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

195

1302

1.50

6.88

6.8

6.6

11.5

mg/l

0.01

182

1200

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

273

1947

1.41

6.83

1.1

18.6

10.4

au/ml

0.43

122

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

646

5208

1.25

6.83

8.5

9.4

24.2

24.3

mmol/l

0.02

600

4884

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

423

3233

1.32

6.82

2.8

2.6

—

(3052851) Hemolysis interference index of Serum or Plasma

425

3252

1.32

6.79

3.2

3.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

210

1428

1.48

6.79

1.4

330.2

334.1

pmol/l

0.05

168

1083

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1056

8965

1.19

6.69

1.3

1.2

123.1

146.4

iu/ml

1.27

398

3446

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

298

2169

1.38

6.63

1.7

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

441

3416

1.30

6.47

2.6

2.3

426.1

558.6

ug/l

0.55

406

3180

(3000492) Spirometry study

1286

11145

1.17

6.38

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2163

19450

1.13

6.36

1.3

12.6

11.3

u/ml

0.15

851

7823

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

113

2.75

6.35

3.8

2.5

—

(3025130) Human papilloma virus identified in Specimen

272

1966

1.39

6.33

1.8

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2285

20628

1.13

6.30

1.3

29.5

32.5

iu/ml

0.36

692

6354

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

448

3492

1.29

6.28

2.3

2.2

3.0

g/l

0.74

366

2720

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2865

1.32

6.23

2.3

2.1

38.0

g/l

0.07

344

2475

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

299

2205

1.36

6.17

1.3

3.7

ug/l

0.01

257

1997

(4034850)

262

3576

0.73

6.05

10.9

9.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

406

3142

1.30

6.02

2.5

2.3

0.8

g/l

0.12

363

2713

(3020961) Endomysium IgA Ab [Titer] in Serum

723

5984

1.22

6.02

1.1

332.3

227.0

titre

0.18

162

(3004588) Protein electrophoresis panel - Serum or Plasma

787

6570

1.21

6.00

2.3

—

(3019060) Gas panel - Arterial blood

770

6417

1.21

5.98

4.9

4.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

131

828

1.59

5.98

2.6

2.7

498.7

516.6

e6/l

0.18

104

686

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

458

1.80

5.93

2.7

2.2

28.9

28.7

0.02

432

(3007930) Methemoglobin/Hemoglobin.total in Blood

503

4011

1.26

5.89

4.7

5.1

0.9

0.47

471

3742

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

508

4059

1.26

5.85

4.6

5.0

1.6

1.7

0.43

474

3784

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

466

3685

1.27

5.85

1.6

507.7

274.2

titre

0.42

164

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1196

10396

1.16

5.72

3.6

4.0

9.9

24.4

ug/l

1.84

915

8262

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

807

1.58

5.69

2.6

2.7

0.2

e9/l

0.96

106

686

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4178

39141

1.10

5.66

3.4

3.3

54.5

70.3

ng/l

0.32

2534

24357

(3016244) Insulin [Units/volume] in Serum or Plasma

127

808

1.58

5.66

3.3

3.4

22.0

28.9

mu/l

1.19

119

764

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

674

1.62

5.48

1.6

1.5

24.8

21.5

u/ml

0.21

148

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

106

652

1.63

5.45

1.3

1.2

23.5

20.8

u/l

0.24

556

(3047007) Chlamydophila sp Ab [Presence] in Serum

242

1764

1.38

5.42

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

578

1.67

5.37

1.4

1.3

80.0

63.3

titre

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

276

2058

1.35

5.36

1.9

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

118

2.55

5.35

2.1

2.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

773

6516

1.20

5.35

2.4

3.2

46.1

44.7

u/ml

0.05

752

6275

(1002224) Polysomnography panel

591

4859

1.23

5.29

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

2.52

5.27

1.7

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

214

1537

1.40

5.25

1.1

1.4

1.5

g/l

3.03

200

1385

(3026389) Candida sp identified in Specimen by Organism specific culture

241

1766

1.37

5.24

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

112

706

1.59

5.23

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

234

1711

1.37

5.17

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

573

4712

1.23

5.13

1.6

1.7

2.9

3.6

mg/l

1.65

380

3280

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

140

933

1.51

5.11

1.3

1.2

350.0

141.0

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

140

933

1.51

5.11

1.3

1.2

134.8

181.7

titre

0.46

174

(3004809) Band form neutrophils/100 leukocytes in Blood

231

1690

1.37

5.09

3.2

1.3

1.5

0.45

181

1315

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

332

2563

1.30

5.09

1.4

1.3

3.6

3.7

mmol/l

1.79

305

2410

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

284

2147

1.33

5.06

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

284

2147

1.33

5.06

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

102

1601

0.63

5.04

5.0

5.2

377.1

366.1

umol/l

0.32

1375

(3047181) Lactate [Moles/volume] in Blood

409

3247

1.27

5.03

5.0

5.8

1.2

1.3

mmol/l

1.09

349

2847

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.45

5.03

2.8

3.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

169

1174

1.44

5.02

1.3

1.2

69.2

60.3

u/l

0.43

114

777

(4094501)

354

2763

1.29

5.00

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

776

6586

1.19

5.00

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

1782

1.36

4.98

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

143

963

1.49

4.97

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

257

1923

1.34

4.92

1.6

1.5

0.6

0.7

g/l

1.12

209

1456

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1153

13105

0.87

4.90

4.5

4.2

32.8

32.4

0.62

824

9190

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

601

1.62

4.89

1.4

1.3

1146.0

340.7

titre

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

239

1771

1.36

4.88

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

298

2282

1.31

4.86

1.5

0.4

nmol/l

0.37

242

1787

(3038515) Glucose [Moles/volume] in Venous blood

256

1918

1.34

4.86

3.5

3.2

7.4

7.5

mmol/l

0.09

250

1876

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

106

672

1.58

4.86

1.3

1.2

86.9

86.2

u/l

0.03

585

(40757494) Bilirubin.total [Moles/volume] in Blood

557

1.64

4.82

2.8

2.2

17.4

23.9

umol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

311

2399

1.30

4.82

3.2

2.4

119.4

105.1

ug/min

0.24

210

1463

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

440

3545

1.25

4.79

3.3

3.6

182.5

1843.2

u/ml

1.38

362

3037

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

505

1.67

4.77

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

329

2562

1.29

4.75

1.4

16.6

27.5

e6/l

0.72

255

1985

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

329

2565

1.29

4.71

1.5

1.4

791.6

2666.1

e6/l

0.66

265

2096

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

947

8215

1.16

4.69

2.4

2.3

8.8

7.2

ug/l

0.73

829

7162

(36660697) Celiac disease serology panel - Serum

1115

9808

1.15

4.57

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.40

4.56

5.9

4.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

379

3022

1.26

4.54

1.9

2.1

10.8

10.9

mg/l

0.12

355

2829

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

456

3714

1.24

4.52

1.6

12.6

6.2

iu/ml

0.30

804

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

341

1.79

4.50

1.7

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

213

1572

1.36

4.50

1.8

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

436

3542

1.24

4.44

1.1

5.7

6.0

u/ml

0.04

492

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

234

1757

1.34

4.42

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

267

2045

1.31

4.39

3.5

3.1

1.4

1.6

mmol/l

4.00

261

1994

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

130

883

1.48

4.39

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

192

1405

1.37

4.30

1.7

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

291

2269

1.29

4.21

1.4

24.2

26.3

u/l

0.57

247

1871

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.14

4.20

1.1

—

(3020891) Body temperature

477

3940

1.22

4.16

5.9

4.7

—

(40768441) Liver Pathology biopsy report

120

812

1.48

4.15

1.5

1.4

—

(3039000) Anion gap in Blood

288

2251

1.29

4.10

6.0

6.8

11.2

11.3

mmol/l

0.10

257

2005

(3018572) Chloride [Moles/volume] in Blood

288

2252

1.28

4.09

6.0

6.8

105.4

105.2

mmol/l

0.40

257

2006

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

175

1273

1.38

4.08

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

443

1.65

4.06

1.7

2.2

—

(4027681)

117

792

1.48

4.05

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

529

1.59

4.03

2.0

1.7

2.0

1.9

umol/l

0.24

492

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

453

1.64

3.99

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

453

1.64

3.99

1.7

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

176

1287

1.37

3.99

2.0

1.5

39.7

29.6

iu/ml

0.22

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

361

2910

1.25

3.99

3.1

3.2

31.0

47.0

mg/l

2.26

288

2365

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

362

2921

1.25

3.96

1.4

1.3

516.2

497.9

mg/l

0.24

338

2778

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

138

969

1.43

3.96

2.3

2.1

20.0

19.5

nmol/l

0.24

131

918

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

611

1.54

3.95

1.2

1.1

1560.9

1533.0

miu/ml

0.09

611

(3034770) Mitochondria Ab [Titer] in Serum

392

3194

1.23

3.93

1.3

303.3

990.4

titre

—

111

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

158

1140

1.39

3.89

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

489

4082

1.21

3.86

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

249

1927

1.30

3.85

1.4

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

458

1.62

3.84

4.6

3.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

360

2916

1.24

3.82

3.1

3.2

72.3

71.5

mg/l

0.01

284

2366

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

193

1.97

3.80

1.9

1.5

116.2

120.7

ng/l

0.08

193

(21494890) Protein electrophoresis panel - 24 hour Urine

137

970

1.42

3.78

1.6

2.1

—

(4268621)

176

1300

1.36

3.77

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1705

15574

1.11

3.77

1.8

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

154

2.08

3.71

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

245

1903

1.29

3.70

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

128

2.19

3.69

1.2

1.1

—

(4062490)

166

1221

1.36

3.66

1.5

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

394

3242

1.22

3.63

1.4

1.3

64.9

141.5

titre

2.79

295

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

176

1.99

3.62

2.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

130

922

1.41

3.57

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

130

922

1.41

3.57

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

112

773

1.45

3.57

1.1

7.1

8.3

iu/ml

0.21

189

(3016038) Potassium [Moles/volume] in Urine

643

1.50

3.55

1.1

1.2

29.2

35.4

mmol/l

1.83

552

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

2843

1.23

3.55

3.1

3.2

1.3

2.5

ratio

1.45

247

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

130

924

1.41

3.53

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

129

917

1.41

3.51

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

361

1.66

3.50

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

131

2.14

3.50

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

117

818

1.43

3.49

1.5

1.3

5.0

5.3

umol/l

0.43

111

760

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

129

918

1.41

3.49

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

918

1.41

3.49

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

861

1.42

3.46

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

861

1.42

3.46

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

861

1.42

3.46

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

244

1917

1.28

3.41

1.3

1.2

2.6

3.4

u/ml

0.55

640

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

110

764

1.44

3.41

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

274

1.75

3.39

1.4

1.1

—

(3045414) Leukocytes [Presence] in Urine

598

5144

1.17

3.39

2.0

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

297

2392

1.25

3.37

4.2

3.2

8.7

8.4

kpa

2.66

277

2219

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

256

2027

1.27

3.36

1.8

1.9

179.6

188.2

pmol/l

0.65

243

1916

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

137

993

1.38

3.35

1.1

255.1

246.7

mg/l

0.21

117

870

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

210

1.86

3.33

8.8

4.3

88.0

72.5

u/l

0.15

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

398

1.61

3.31

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

269

1.75

3.30

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

715

6248

1.15

3.30

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

245

1935

1.27

3.29

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

140

1022

1.37

3.28

1.2

39.1

40.5

mg/l

0.17

120

851

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1180

10652

1.12

3.27

3.3

3.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2016

18700

1.09

3.24

1.7

1203.9

1169.6

nmol/l

0.87

1560

14290

(3038177) Helicobacter pylori Ab [Presence] in Serum

258

2056

1.26

3.23

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

401

1.60

3.22

1.1

1.2

0.1

0.2

g/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

163

1224

1.34

3.20

1.4

1.3

6.1

6.7

g/l

1.80

131

853

(3024139) IgG subclass 3 [Mass/volume] in Serum

163

1224

1.34

3.20

1.4

1.3

0.4

g/l

0.13

132

851

(3028192) IgG subclass 2 [Mass/volume] in Serum

163

1224

1.34

3.20

1.4

1.3

2.7

2.9

g/l

1.44

131

851

(1761868) Lipid panel - Serum or Plasma

4379

41857

1.07

3.18

2.8

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

368

3053

1.21

3.17

1.7

1.9

3.5

7.1

iu/l

0.73

110

1181

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

243

1928

1.27

3.16

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

226

1778

1.28

3.15

1.2

1.1

114.0

117.8

1.10

210

1600

(3036603) Volume of Urine

104

727

1.43

3.14

1.5

1.7

2099.7

1932.2

0.34

161

(3000330) Specific gravity of Urine by Test strip

606

5254

1.16

3.13

4.3

3.2

—

(3003694) ABO and Rh group [Type] in Blood

3633

34527

1.07

3.12

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

389

1.60

3.11

2.4

1.7

5532.8

11728.8

u/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

169

1283

1.32

3.09

1.1

—

3.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

234

1855

1.27

3.08

1.3

1.2

3.7

4.0

u/ml

0.20

116

808

(21494755) Public health laboratory ask at order entry panel

1171

12909

0.90

3.08

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

195

2498

0.78

3.07

2.1

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

415

1.57

3.04

1.1

88.5

91.8

0.40

174

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.43

3.04

1.2

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1390

12710

1.10

3.03

25.7

22.1

1.3

inr

0.49

185

1916

(3034274) Bile acid [Moles/volume] in Serum --fasting

261

2100

1.25

3.03

2.3

2.2

5.4

6.2

umol/l

0.77

205

1528

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1935

17973

1.09

3.01

2.2

2.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

586

1.47

2.99

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

367

3068

1.20

2.95

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1488

13681

1.10

2.91

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1546

14245

1.10

2.89

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

405

1.56

2.88

1.1

92.1

91.1

0.07

175

(3041806) Other cells [#/volume] in Blood by Manual count

599

1.46

2.88

1.6

1.5

—

(3051651) Icteric interference index of Serum or Plasma

649

1.44

2.87

4.7

3.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

322

2666

1.21

2.87

1.1

1.8

1.7

u/ml

0.05

132

1062

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

366

3068

1.20

2.86

1.8

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

282

1.67

2.84

1.8

1.9

23.8

37.0

u/l

0.41

257

(40768795) Lymph node Pathology biopsy report

144

1085

1.33

2.81

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

232

1860

1.25

2.81

1.1

2.8

3.2

u/ml

0.19

116

948

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

416

1.54

2.80

1.9

2.1

8.4

9.6

mg/l

1.05

340

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

440

1.53

2.80

1.1

63.6

524.3

ng/l

—

101

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.64

2.79

1.3

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

376

3169

1.19

2.78

1.4

285.4

280.2

ug/g

0.20

219

1788

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

612

1.44

2.78

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

147

1113

1.32

2.78

2.9

2.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

756

0.62

2.77

1.7

2.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

442

1.52

2.75

2.9

2.7

75.0

162.4

au/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.20

2.72

1.8

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

682

1.41

2.71

1.2

1.5

5.2

5.9

u/l

0.94

581

(3023410) Appearance of Cerebral spinal fluid

154

1179

1.31

2.70

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

154

1179

1.31

2.70

1.3

1.4

10.7

11.3

mmol/l

0.26

240

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

167

1295

1.29

2.67

1.2

1.1

92.0

95.5

0.93

160

1212

(3037121) Protein [Mass/volume] in Urine

430

3683

1.17

2.65

4.2

3.1

0.3

g/l

0.21

236

1586

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1747

16250

1.09

2.64

2.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.55

2.61

1.2

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

1151

1.31

2.60

1.1

—

(3022689) Creatine [Moles/volume] in Urine

305

1.61

2.60

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

392

1.53

2.59

2.6

2.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

290

1.62

2.58

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

474

1.48

2.56

3.2

3.3

8.1

8.0

mg/l

0.08

379

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

107

2.06

2.56

1.6

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

283

1.63

2.56

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

307

2566

1.20

2.53

1.3

46.8

43.5

u/ml

0.12

260

(3036782) Glucose [Moles/volume] in Pleural fluid

112

828

1.36

2.52

1.3

1.4

6.3

mmol/l

0.04

104

765

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

117

871

1.35

2.52

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

233

1898

1.23

2.49

2.9

3.6

39.7

31.3

u/ml

0.25

226

1834

(3020717) Zinc [Moles/volume] in Serum or Plasma

619

1.41

2.47

1.4

1.5

25.1

24.9

umol/l

0.01

588

(3045424) Erythrocytes [Presence] in Urine

234

1909

1.23

2.47

1.6

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

184

1463

1.26

2.44

2.2

1.7

6977.8

1475.2

titre

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

288

1.60

2.41

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

440

1.48

2.40

1.2

0.3

g/l

0.10

348

(3013512) EKG study

3115

29687

1.06

2.39

3.9

3.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

242

1.65

2.39

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

193

1548

1.25

2.39

1.7

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

199

1602

1.25

2.38

1.4

1.3

0.3

0.2

nmol/l

0.09

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

441

1.48

2.38

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

227

1854

1.23

2.38

3.5

2.7

—

(4306422)

228

1866

1.23

2.35

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

267

1.61

2.33

1.2

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

197

1590

1.24

2.32

1.4

1.3

0.6

1.6

nmol/l

0.68

192

1536

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

660

5891

1.13

2.31

1.7

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

154

1209

1.28

2.29

3.6

3.1

3.6

10.3

nmol/l

0.84

148

1177

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

125

957

1.31

2.26

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

301

0.46

2.26

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

641

5722

1.13

2.24

1.5

—

(3032641) Amino acids panel - Urine

5.56

2.21

1.0

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

265

2219

1.20

2.19

2.9

3.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

246

2046

1.21

2.18

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

288

1.56

2.18

1.2

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

304

1.55

2.18

1.5

1.6

7.6

8.8

ug/l

3.04

304

(3027944) Amphetamines [Presence] in Urine

505

5716

0.88

2.16

1.6

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

114

868

1.32

2.16

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

281

1.57

2.15

1.1

—

(3045142) Bone marrow Pathology biopsy report

138

1079

1.28

2.15

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

109

826

1.32

2.14

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

134

1045

1.29

2.13

1.5

1.3

—

titre

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

290

1.55

2.12

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

139

1095

1.27

2.05

4.1

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

437

3833

1.14

2.04

2.2

1.9

2.4

2.1

ug/l

0.14

392

3377

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

660

1.35

2.03

1.1

1.3

8.1

nmol/l

1.70

131

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

506

4485

1.13

2.02

1.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

513

5771

0.88

2.02

1.6

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

177

1438

1.23

2.01

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

244

2047

1.20

2.00

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

133

1.81

1.98

1.0

0.0

3.1

u/ml

0.58

(3044290) Cell count panel - Cerebral spinal fluid

283

2410

1.18

1.97

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

264

1.55

1.96

1.1

1.0

7.3

6.5

mg/g

0.38

251

(3000475) Leukocytes [#/volume] in Synovial fluid

290

2475

1.18

1.96

1.6

18066.2

12465.9

e6/l

0.48

212

1788

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

214

1778

1.21

1.96

1.5

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

112

1.88

1.95

3.3

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

103

786

1.31

1.95

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

854

7810

1.10

1.95

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

387

1.45

1.93

1.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

391

4461

0.87

1.93

1.6

2.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

421

3701

1.14

1.92

2.3

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

182

1492

1.22

1.91

2.5

2.6

108.3

1100.5

u/ml

0.84

177

1395

(4198724)

618

0.66

1.91

2.0

2.6

—

(3028300) Cannabinoids [Presence] in Urine

519

5811

0.89

1.91

1.6

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

206

1714

1.20

1.87

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

382

1.44

1.86

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

276

1.52

1.86

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

201

1671

1.21

1.85

1.3

1.4

62.5

63.7

mmol/l

0.18

152

1331

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

837

1.29

1.85

1.1

—

(3027008) Opiates [Presence] in Urine

519

5798

0.89

1.84

1.6

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

263

2241

1.18

1.84

1.1

2.6

2.0

u/ml

0.34

569

(3008898) HLA-B27 [Presence]

510

4554

1.12

1.84

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

110

856

1.29

1.83

2.0

1.9

1.2

g/24h

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

760

1.30

1.82

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

278

2385

1.17

1.79

1.1

6.5

5.7

u/ml

0.32

153

1238

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

291

2506

1.16

1.79

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

344

1.46

1.79

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

298

2572

1.16

1.78

3.8

3.0

24.3

24.7

mmol/l

1.01

259

2243

(3000034) Microalbumin [Mass/volume] in Urine

120

948

1.27

1.78

3.2

3.0

60.2

53.2

mg/l

0.11

698

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

411

1.41

1.77

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

411

1.41

1.77

1.6

2.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

122

966

1.27

1.77

1.3

1.1

—

59.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

755

1.30

1.77

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

381

3351

1.14

1.76

1.3

39.4

36.8

u/ml

0.06

222

(3039162) Centromere protein B Ab [Units/volume] in Serum

184

1526

1.21

1.75

1.3

52.9

57.5

u/ml

0.10

106

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

162

1328

1.22

1.74

1.3

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.50

1.73

1.6

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.22

1.73

1.3

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.22

1.73

3.3

3.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

340

2971

1.15

1.73

5.1

4.3

3.9

mmol/l

0.34

325

2788

(3044941) Cell count panel - Synovial fluid

189

1574

1.20

1.73

1.3

1.4

—

(4146454)

1021

0.75

1.73

3.1

2.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

110

1.82

1.72

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

110

864

1.28

1.72

1.3

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.92

1.72

1.1

—

(3016879) Cocaine [Presence] in Urine

477

5327

0.89

1.71

1.6

2.1

—

(3011288) Drugs identified in Urine by Screen method

344

3919

0.87

1.70

2.1

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

104

813

1.28

1.69

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

265

2278

1.17

1.69

1.1

0.9

1.2

u/ml

0.68

110

979

(3030313) Adrenal Ab [Titer] in Serum

126

1.75

1.67

1.2

1.1

—

(21494434) Karyotype in Bone marrow

104

815

1.28

1.66

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

417

1.39

1.66

1.6

2.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

417

1.39

1.66

1.6

1.5

15.0

15.1

pmol/l

0.03

345

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

204

1.57

1.64

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.03

1.64

1.1

1.0

—

(3019225) pH of Specimen

966

10400

0.92

1.63

6.0

4.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

102

800

1.28

1.63

1.4

1.3

345.9

369.1

u/l

0.19

757

(3012565) Volume of 24 hour Urine

538

1.34

1.63

2.4

2.1

1883.0

1988.8

0.43

485

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

110

871

1.27

1.63

1.3

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

530

1.34

1.62

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

530

1.34

1.62

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

530

1.34

1.62

1.5

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

344

1.43

1.61

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

531

1.34

1.60

1.5

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.50

1.59

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

112

892

1.26

1.59

1.4

35.1

31.6

nmol/l

0.63

816

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.00

1.58

1.1

1.0

1.4

4.8

u/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

222

1.53

1.58

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

222

1.53

1.58

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

222

1.53

1.58

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

421

1.38

1.58

1.8

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

155

1280

1.21

1.58

1.2

1.3

—

31.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

218

1859

1.18

1.56

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

129

1.71

1.56

1.0

0.0

0.5

u/ml

0.89

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

280

1.47

1.56

2.9

2.8

105.0

124.1

ng/l

0.31

143

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.11

1.54

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

440

1.37

1.54

3.5

2.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.03

1.53

1.5

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

224

1919

1.17

1.52

1.1

2.7

4.6

u/ml

1.44

762

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

121

978

1.24

1.52

2.8

3.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

241

1.50

1.51

1.5

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

154

1278

1.21

1.50

1.3

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

193

1.56

1.50

1.6

1.3

474.0

84.2

titre

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

730

1.28

1.50

1.5

1.3

76.1

101.1

pmol/l

0.23

228

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

333

1.41

1.49

1.7

217.2

122.8

au/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

696

1.28

1.48

1.2

1.1

1.0

1.1

u/l

1.89

306

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

618

1.30

1.47

1.3

22.4

12.7

u/l

0.51

569

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

124

1.69

1.46

1.0

0.0

0.6

u/ml

1.09

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

227

1.50

1.45

1.1

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

665

1.28

1.42

1.1

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.79

1.42

1.1

1.0

0.1

1.7

u/ml

0.64

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

270

1.45

1.41

1.1

88.9

78.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

328

2909

1.13

1.40

1.5

1.4

83.7

127.7

pmol/l

2.31

319

2829

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

447

0.67

1.40

2.2

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

246

1.46

1.39

1.3

1.2

278.3

317.4

pmol/l

0.48

177

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

317

2807

1.13

1.39

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

209

1797

1.17

1.39

1.0

1.1

6.1

4.9

u/ml

0.35

752

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

342

3043

1.13

1.39

1.3

5.2

6.5

u/ml

0.19

308

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

607

1.29

1.37

1.9

1.8

—

(3026726) Creatinine [Moles/volume] in Specimen

1.80

1.36

3.7

2.5

363.9

440.3

umol/l

0.14

(1616796) Gas panel - Central venous blood

267

2341

1.14

1.36

4.9

3.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

239

2080

1.15

1.36

4.8

2.0

0.8

nmol/l

0.31

202

1751

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

529

1.31

1.36

8.6

5.7

52.4

7248.7

u/ml

0.55

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.94

1.36

1.4

1.2

1.3

1.5

mg/l

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.94

1.36

1.4

1.0

—

(3045788) Cell count panel - Pleural fluid

101

813

1.24

1.35

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

697

1.26

1.35

1.7

1.5

9.2

4.9

u/l

0.58

334

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

281

1.42

1.35

1.2

1.1

68.1

54.5

u/ml

0.52

273

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.75

1.34

1.1

1.2

—

(3024263) Appearance of Synovial fluid

548

1.30

1.34

2.0

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

167

1.56

1.33

1.3

1.6

36.4

98.0

ng/l

1.44

101

(3027456) Digoxin [Moles/volume] in Serum or Plasma

185

1582

1.17

1.33

3.4

3.0

0.8

nmol/l

0.17

144

1189

(3023419) Bacteria identified in Sputum by Culture

145

1214

1.20

1.33

2.7

2.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

105

1.72

1.32

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.84

1.29

1.1

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.78

1.28

8.0

8.6

39.4

58.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.94

1.27

1.5

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.94

1.27

1.2

2.0

25.0

20.5

mmol/l

0.38

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

154

1.56

1.25

1.1

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

244

1.44

1.25

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

344

3086

1.12

1.24

1.3

2.9

8.6

u/ml

5.03

485

(3047189) Immunofixation for 24 hour Urine

432

1.32

1.24

1.3

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

573

1.28

1.23

1.0

97.1

93.8

0.29

459

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

920

8630

1.07

1.23

5.6

3.6

1.2

mmol/l

0.00

799

7566

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

270

1.41

1.23

1.1

75.6

72.9

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.63

1.21

1.4

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

916

8597

1.07

1.21

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

640

0.75

1.21

1.0

733.5

724.3

ng/l

0.05

440

(3004451) EKG impression Narrative

461

1.30

1.19

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

128

1073

1.19

5.0

3.7

30.3

44.0

u/ml

1.54

128

1063

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

180

1553

1.16

1.19

1.0

1.1

0.5

0.4

u/ml

0.11

342

(3025315) Body weight

1.74

1.18

6.5

3.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

784

0.78

1.18

20.0

18.8

1427.5

2627.9

nmol/l

0.49

758

(3042517) Benzodiazepines panel - Urine

169

0.53

1.18

1.3

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

127

1065

1.19

1.18

1.3

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

149

1.54

1.16

1.0

0.0

0.1

u/ml

1.32

(3008757) Leukocyte morphology finding [Identifier] in Blood

134

1131

1.19

1.16

4.4

3.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

759

0.78

1.16

15.8

12.9

895.3

815.4

nmol/l

0.68

728

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

291

1.38

1.14

1.4

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

1.14

0.0

7.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

1.14

0.0

1.2

—

3405.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.85

1.13

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

448

1.30

1.13

1.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

214

1880

1.14

1.12

2.4

2.5

13.1

13.2

0.30

207

1855

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

642

0.76

1.11

1.0

39.2

43.2

ng/l

0.27

444

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.26

1.10

1.6

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

503

1.27

1.10

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

243

1.40

1.09

1.1

1.3

5.3

u/ml

0.96

173

(3028433) Virus identified in Specimen by Culture

382

1.31

1.06

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

637

0.77

1.06

1.0

279.4

335.3

ng/l

0.87

451

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.79

1.04

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

288

1.36

1.04

1.2

1.3

18.0

16.9

umol/l

0.64

255

(3050794) Legionella sp Ab [Presence] in Serum

1.67

1.03

1.5

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1205

11472

1.06

1.03

1.7

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.27

1.03

1.6

1.4

2.1

2.0

mmol/24h

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.27

1.03

1.2

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.96

1.03

1.4

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.96

1.03

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

178

1555

1.15

1.03

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.06

1.02

7.3

5.5

402.6

443.6

umol/l

—

(3028717) Thiamine [Mass/volume] in Blood

130

1.54

1.02

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

114

1.58

1.02

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

206

2328

0.88

1.02

3.1

3.4

24.4

26.4

mg/l

0.33

139

1419

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

155

1.48

1.00

1.4

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

147

1.50

1.00

1.1

1.4

45.2

56.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

529

1.25

0.99

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

448

4131

1.09

0.99

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.17

0.98

2.6

3.5

—

(44813793)

105

884

1.19

0.98

1.1

—

(3022670) pH of Venous cord blood

0.00

0.97

0.0

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

5.4

—

4.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

950

1.18

0.96

1.2

1.4

153894.2

99798.6

e6/l

0.33

663

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

238

2130

1.12

0.96

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

116

1.55

0.96

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

174

0.57

0.96

1.5

1.2

1.7

mmol/l

—

103

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

140

1210

1.16

0.96

1.0

1.1

—

(4281824)

106

1248

0.85

0.94

1.1

—

(3017704) Immunofixation for Urine

497

1.25

0.94

1.1

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.77

0.94

1.3

1.7

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

1.89

0.94

7.0

5.1

13.9

16.9

mmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1433

14932

0.95

0.93

1.7

1.4

1.00

1278

13192

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

110

936

1.18

0.92

2.0

1.8

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.71

0.92

1.3

1.4

17.1

37.3

—

(3014051) Protein [Presence] in Urine by Test strip

235

2615

0.90

0.92

2.5

2.1

—

(3044927) Protein electrophoresis panel - Urine

108

920

1.18

0.90

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

102

1.57

0.90

1.3

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

121

1043

1.16

0.88

2.4

3.3

58.4

57.6

0.12

676

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

280

1.32

0.88

1.3

201.7

119.5

nmol/l

0.60

211

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

404

1.26

0.87

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.00

0.87

3.0

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

372

4025

0.92

0.83

5.5

3.7

24.4

24.8

mmol/l

2.68

340

3725

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

561

1.21

0.82

1.3

1.1

19.8

24.3

u/l

0.46

434

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.69

0.82

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

240

1.33

0.82

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

272

0.70

0.81

2.1

13.4

16.1

umol/l

1.00

272

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

177

0.62

0.81

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

264

2406

1.10

0.80

2.7

2.1

128.6

130.1

g/l

0.45

196

1735

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

122

1.48

0.79

3.1

2.3

1.1

0.7

u/field

0.69

122

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

198

1.36

0.79

1.4

0.2

0.3

nmol/l

1.13

133

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

365

1.26

0.79

2.6

3.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

500

1.22

0.79

2.1

97.9

142.1

ug/min

0.25

115

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.79

0.0

1.1

—

70.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

564

1.21

0.79

1.3

1.1

75.7

86.5

u/l

0.78

450

(3008116) Ketones [Moles/volume] in Urine by Test strip

216

1.34

0.78

1.3

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

121

1057

1.15

0.76

1.5

2156.7

2301.3

e6/l

0.06

757

(3011325) HIV 1+2 Ab [Presence] in Serum

1.70

0.75

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

687

1.18

0.75

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

187

1682

1.11

0.75

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.60

0.74

1.1

0.0

0.3

u/ml

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.67

0.74

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

397

1.24

0.72

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

237

1.31

0.72

1.1

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

159

0.63

0.71

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.62

0.71

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.75

0.71

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

775

1.16

0.70

1.4

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.71

0.69

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

494

4650

1.06

0.69

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

955

0.86

0.69

1.3

1.4

1.3

promille

0.01

719

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

836

0.85

0.69

1.8

2.0

2.2

1.9

u/field

0.20

362

(40763791) Oxygen content in Venous blood by calculation

1.85

0.68

2.0

5.2

11.6

12.7

ml/dl

—

(3017732) Neutrophils [#/volume] in Blood

851

8142

1.05

0.67

2.4

2.7

4.2

4.1

e9/l

0.47

695

6431

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

788

1.16

0.67

1.1

ratio

0.37

272

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

249

1.29

0.67

1.3

1.6

0.4

ug/l

0.10

158

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.63

0.66

1.0

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

411

1.22

0.66

1.0

1.1

9.2

7.4

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

855

1.15

0.66

1.5

1.3

1.7

1.3

u/ml

0.25

357

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

145

1.38

0.65

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

176

1594

1.11

0.65

1.2

1.3

47.2

33.9

u/l

0.45

154

1391

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.59

0.65

4.3

9.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

105

922

1.14

0.65

1.1

1.3

2.1

2.0

mmol/l

0.15

867

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.61

0.65

1.2

1.0

7.4

8.3

mmol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

117

1319

0.89

0.64

1.8

2.0

28.1

26.7

mg/l

0.09

332

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

166

0.66

0.64

8.3

7.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

423

1.21

0.63

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

728

1.15

0.63

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

234

1.28

0.62

1.5

1.3

71.4

79.0

mu/l

0.10

177

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

243

1.28

0.62

10.6

7.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

106

935

1.13

0.62

1.5

35.7

32.4

0.35

568

(3029075) Extractable nuclear Ab panel - Serum

342

1.23

0.62

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

102

0.59

0.62

1.7

2.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

805

1.14

0.61

1.1

1.2

2.2

u/ml

0.45

201

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.60

0.61

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

133

1194

1.12

0.59

1.5

33.3

32.9

g/l

0.13

117

1078

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

227

1.28

0.59

2.1

1.5

—

(3022621) pH of Urine by Test strip

708

7400

0.95

0.59

2.7

2.9

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.59

0.0

1.0

—

385.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

201

1.29

0.58

1.7

2.3

—

(4038314)

1.56

0.58

1.1

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

476

4510

1.06

0.58

1.3

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.46

0.57

3.2

2.9

8.0

70.0

pmol/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

171

1872

0.91

0.57

1.3

1.4

6.7

7.0

mmol/l

0.91

127

1360

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

558

1.17

0.57

1.4

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

474

4494

1.06

0.56

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

238

1.26

0.56

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

341

0.79

0.55

1.5

1.4

66.8

64.7

0.13

279

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

181

1659

1.09

0.55

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

302

1.23

0.55

1.2

1.3

46.4

51.0

0.27

254

(3040151) Glucose [Moles/volume] in Capillary blood

108

1208

0.89

0.55

5.1

11.9

7.3

7.4

mmol/l

0.10

1007

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

111

993

1.12

0.54

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

107

956

1.12

0.54

1.5

52095.0

64148.0

e6/l

0.15

556

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

476

4523

1.05

0.53

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

402

3803

1.06

0.53

1.7

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.53

1.2

1.1

163.7

259.1

nmol/l

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.45

0.53

2.9

3.2

—

0.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

476

4526

1.05

0.52

1.3

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.41

0.51

3.8

1.7

191.8

182.0

ng/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

564

1.15

0.51

1.5

1.7

4.2

nmol/l

1.94

461

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

202

0.74

0.50

1.5

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.36

0.50

1.4

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

291

0.79

0.49

1.0

1.2

40.4

39.3

g/l

—

161

(40761539) Cells [Type] in Urine sediment by Light microscopy

270

1.22

0.49

1.5

1.1

—

(3005033) Fetal Nuchal fold Thickness US

382

3619

1.06

0.49

1.3

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

266

2492

1.07

0.49

1.3

1.2

3.3

3.6

u/ml

0.09

179

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

289

2717

1.07

0.48

1.4

—

(4024509)

1049

0.90

0.48

1.4

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

154

1.30

0.48

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.48

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

333

0.81

0.47

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.49

0.47

1.1

1.3

489.6

525.5

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

751

0.88

0.46

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

164

1.28

0.46

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

391

3717

1.05

0.46

1.4

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

221

0.77

0.46

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.61

0.45

1.2

1.1

14.7

18.0

g/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

382

3631

1.05

0.45

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

320

0.81

0.45

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

255

1.22

0.45

1.3

43.7

38.3

0.25

169

(3012501) Base excess in Blood by calculation

254

2386

1.07

0.45

4.7

3.9

2.4

2.5

mmol/l

0.17

161

1598

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

227

2125

1.07

0.44

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

742

1.12

0.44

1.1

1.0

0.2

1.3

u/ml

0.93

108

(3012441) Differential panel - Pleural fluid

101

914

1.11

0.43

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

130

1.31

0.43

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

130

1416

0.92

0.43

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

200

1867

1.07

0.43

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

127

0.71

0.43

1.6

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

820

1.11

0.43

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.61

0.43

1.8

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

294

1.19

0.42

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.42

1.0

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.65

0.42

1.3

1.2

7.8

10.3

mg/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.56

0.42

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

556

1.13

0.42

1.4

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

613

1.13

0.41

1.3

75.7

64.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

334

3174

1.05

0.41

1.5

—

(3034426) Prothrombin time (PT)

425

1.15

0.41

1.3

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

316

0.82

0.41

2.0

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

316

0.82

0.41

2.0

2.8

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.41

0.0

1.9

—

10.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

388

1.16

0.41

1.1

0.3

12.8

u/ml

0.84

220

(3044316) Mercury [Moles/volume] in Urine

0.00

0.41

0.0

2.4

—

8.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

594

0.87

0.41

1.1

11.0

7.7

u/ml

0.38

105

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

213

1.22

0.40

2.3

2.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

155

1440

1.08

0.39

1.3

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

503

4837

1.04

0.39

1.4

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

281

0.82

0.39

1.6

1.4

2.9

2.6

0.05

236

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.41

0.39

1.3

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

155

1442

1.08

0.38

1.3

1.5

—

(46236302) HLA-C [Type] by High resolution typing

1.39

0.38

1.0

—

(40760409) HLA-A [Type] by High resolution

1.39

0.38

1.0

—

(40760410) HLA-B [Type] by High resolution

1.39

0.38

1.0

—

(40763590) HLA-DQ beta [Type]

1.39

0.38

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.34

0.38

3.8

5.7

—

(3032057) Clostridioides difficile [Presence] in Stool

225

0.80

0.37

2.3

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

526

0.87

0.37

1.8

2.3

117.6

141.8

umol/l

0.24

267

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.33

0.37

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

115

1059

1.09

0.37

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

235

0.81

0.36

1.4

1.6

13.6

13.1

g/l

0.07

186

(3033923) Metanephrine [Moles/time] in 24 hour Urine

216

1.20

0.36

1.1

0.5

0.7

umol/24h

1.98

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

597

0.89

0.35

1.3

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

179

0.78

0.35

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.31

0.35

1.1

1.2

1.8

1.7

umol/24h

0.29

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

108

1.30

0.35

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

123

0.73

0.35

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.40

0.35

24.5

8.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

879

0.91

0.35

1.4

1.2

89.8

41.5

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.37

0.34

1.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

134

1250

1.07

0.33

2.5

2.1

32.9

32.8

0.17

134

1240

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

903

1.09

0.32

1.0

1.1

298.1

290.0

mg/l

0.51

806

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

153

1435

1.07

0.32

1.3

1.5

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.28

0.32

1.0

1.1

505.2

313.3

u/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

1437

1.07

0.31

1.3

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

197

0.81

0.31

1.4

1.6

—

(40768806) Pleura Pathology biopsy report

102

945

1.08

0.30

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

194

2044

0.95

0.29

3.0

3.5

299.4

526.2

u/ml

0.43

181

1862

(3025468) Yersinia sp identified in Specimen by Organism specific culture

152

1432

1.06

0.29

1.3

1.5

—

(3014271) Vancomycin [Susceptibility]

441

0.88

0.29

2.6

2.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

133

1248

1.07

0.29

1.6

54.4

56.1

0.16

788

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

630

1.10

0.29

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

823

1.08

0.29

1.1

0.5

1.5

u/ml

1.24

236

(3038026) Centromere Ab [Units/volume] in Serum

899

0.92

0.28

1.4

1.2

92.1

48.5

u/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

247

2362

1.05

0.28

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

576

0.90

0.28

1.5

1.6

1.1

1.2

nmol/l

0.70

454

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

131

1231

1.06

0.28

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

460

0.89

0.28

1.6

2.3

8.7

9.2

mmol/l

0.41

351

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

412

1.12

0.28

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

156

1475

1.06

0.27

1.3

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

172

0.81

0.27

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

131

1.22

0.27

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

215

1.16

0.26

1.3

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.26

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.70

0.26

1.2

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.30

0.26

1.0

—

(4133840)

320

0.87

0.25

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

848

1.07

0.25

1.8

2.5

—

(3000285) Sodium [Moles/volume] in Blood

123

1.22

0.25

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.28

0.24

1.0

1.1

13.2

11.7

u/l

—

(3006270) Folate [Moles/volume] in Blood

931

0.93

0.24

1.1

396.8

370.7

nmol/l

0.55

803

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

838

0.93

0.23

1.4

1.2

19.0

10.0

u/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

755

1.07

0.23

1.2

1.5

—

(3013762) Body weight Measured

1.32

0.23

1.0

1.2

—

(3013862) HLA-DP [Type]

1.32

0.23

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

941

1.06

0.22

1.6

1.3

1.5

nmol/l

0.70

843

(44806420)

253

0.87

0.22

2.6

2.3

—

(3001729) Color of Synovial fluid

1.25

0.22

1.1

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

454

4422

1.03

0.22

1.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

381

1.10

0.22

1.2

17.9

21.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

210

0.86

0.22

3.1

2.3

6.6

7.6

mmol/l

0.67

122

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

116

1.21

0.22

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

487

1.09

0.22

1.6

1.5

4.0

—

111

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

107

1.22

0.21

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

482

0.91

0.21

4.9

3.9

—

(3022313) Gas panel - Capillary blood

448

4596

0.97

0.21

5.4

3.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

230

1.13

0.20

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3012898) Urea [Moles/volume] in Urine

108

1.20

0.20

1.3

1.5

156.3

174.1

mmol/l

0.25

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

664

1.07

0.20

1.3

1.4

—

(3003129) Base excess in Capillary blood by calculation

250

0.88

0.20

1.9

1.7

0.0

0.7

mmol/l

0.45

235

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

510

1.08

0.19

2.9

2.4

56.2

52.1

umol/l

0.55

429

(3017569) Oxygen content in Arterial blood

462

1.08

0.19

1.9

2.2

—

(3017509) Phencyclidine [Presence] in Urine

156

1.15

0.18

1.9

1.5

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

147

1.16

0.18

1.7

1.9

1.6

mg/l

0.29

129

(40767503) Oxygen content in Capillary blood by calculation

230

2228

1.03

0.17

3.2

2.4

16.5

0.01

144

1139

(3019977) pH of Arterial blood

562

1.07

0.17

2.2

2.8

7.4

0.43

190

(4211845)

621

1.06

0.16

2.8

3.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

101

1.19

0.16

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

680

1.06

0.16

1.3

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

1.17

0.16

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

566

0.94

0.16

2.2

2.0

2.4

ug/l

0.70

470

(40761995) Spermatozoa Progressive [#/volume] in Semen

254

1.10

0.16

2.9

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

254

1.10

0.16

5.8

6.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.10

0.15

2.0

1.5

307.5

317.8

umol/24h

—

(3001019) Free T4 and TSH panel - Serum or Plasma

709

7200

0.98

0.15

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.79

0.15

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

119

0.84

0.15

1.4

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

729

0.95

0.15

2.1

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

161

0.87

0.15

5.7

5.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

759

0.95

0.15

1.4

5.5

mmol/l

0.16

720

(3022475) Manganese [Moles/volume] in Blood

1.10

0.15

1.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

129

0.85

0.14

17.1

10.0

0.3

0.4

umol/l

0.06

120

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

623

6135

1.02

0.14

4.9

3.4

1.3

1.7

mmol/l

1.98

441

4488

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

174

1794

0.97

0.14

1.2

1.1

34.3

6380.6

iu/ml

0.67

435

(3033799) Differential panel - Peritoneal fluid

294

0.92

0.13

2.0

1.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

117

0.85

0.13

6.3

9.0

—

(3048879) Bone marrow aspiration report

273

0.92

0.13

2.6

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

591

0.95

0.12

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

653

6443

1.01

0.12

4.9

3.5

5.1

kpa

2.03

602

5963

(3006462) Nitrate [Presence] in Urine

570

1.05

0.12

2.9

3.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

292

0.92

0.11

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

486

0.95

0.11

2.0

2.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.11

3.5

4.7

—

(3010421) pH of Blood

283

2777

1.02

0.11

4.8

3.8

7.4

1.81

253

2345

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

301

0.93

0.10

2.2

1.9

4063.2

16173.5

e6/l

1.03

163

(3034092) Cytoplasmic Ig cells/100 cells in Blood

163

1.10

0.10

5.2

7.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

632

1.04

0.10

1.2

1.1

1.9

15.0

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

187

0.91

0.10

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

339

1.06

0.10

7.3

6.3

25.6

24.9

mmol/l

0.54

313

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

222

1.08

0.10

1.9

2.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.11

0.09

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

164

1.10

0.09

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

228

2324

0.98

0.09

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

145

0.90

0.09

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

116

1.12

0.09

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.13

0.09

1.0

0.3

0.9

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

194

1.08

0.09

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

206

0.92

0.08

1.1

1.2

164.6

87.8

mg/l

0.18

155

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

390

1.05

0.08

3.6

2.9

30.9

27.7

umol/l

0.43

294

(46235168) Fasting glucose [Moles/volume] in Blood

136

1.10

0.08

1.5

8.1

7.1

mmol/l

—

(3000012) Reticulocyte production index

532

0.96

0.08

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

420

0.95

0.08

5.3

10.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

154

0.91

0.08

1.9

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

236

0.93

0.08

1.2

59.0

389.3

ug/l

1.45

126

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

156

1.09

0.08

2.1

3.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.84

0.07

1.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.12

0.07

1.2

1.3

—

526.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.83

0.07

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

569

1.04

0.07

1.4

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.07

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

639

1.03

0.07

1.4

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

255

0.94

0.07

1.1

—

1.7

—

(3008295) Osmolality of Serum or Plasma

110

1075

1.02

0.07

1.6

1.4

280.1

280.4

mosm/kgh2o

0.04

831

(3038071) Oxygen [Partial pressure] in Mixed venous blood

216

1.06

0.06

13.0

7.5

—

(3009343) pH of Capillary blood

641

6360

1.01

0.06

4.9

3.5

7.4

0.02

837

(3015183) Erythrocyte sedimentation rate

660

1.03

0.06

1.1

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

609

0.97

0.06

1.1

1.2

225.2

302.3

u/l

0.87

560

(3014891) Appearance of Pleural fluid

119

1.09

0.06

2.5

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

563

1.03

0.05

1.4

1.5

—

(3035880) pH of Pleural fluid

484

1.03

0.05

1.3

—

(3042631) Mycobacterium sp identified in Specimen

129

1311

0.98

0.05

3.1

2.7

—

(3002619) Bacteria identified in Specimen by Culture

232

0.95

0.05

1.4

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

215

2126

1.01

0.04

3.7

2.8

31.4

34.2

umol/l

1.14

182

1818

(3013637) Mi-2 Ab [Presence] in Serum

272

0.96

0.04

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

272

0.96

0.04

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

272

0.96

0.04

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

272

0.96

0.04

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

150

1.07

0.04

1.3

1.1

—

(4212803)

1.10

0.04

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

120

1182

1.02

0.04

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

336

3386

0.99

0.04

1.5

1.4

—

(44806071)

170

0.94

0.04

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

409

4117

0.99

0.04

2.0

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

180

1.06

0.04

1.8

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

190

1.05

0.04

1.1

1.0

66.2

75.8

ug/l

0.81

163

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

131

1326

0.99

0.03

1.5

1.6

7.4

7.7

mmol/l

0.75

795

(40761536) Microorganisms panel - Urine sediment

992

9952

1.00

0.03

4.8

3.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

599

1.02

0.02

1.9

1.7

1.0

2.8

u/field

2.14

429

(3044007) Cell count panel - Peritoneal fluid

271

1.03

0.02

2.1

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2248

22511

1.00

0.02

1.6

1.7

26294221.5

31273523.2

pmol/l

0.19

1913

18946

(3052592) Norovirus Ag [Presence] in Stool

192

1.04

0.02

1.1

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

198

0.96

0.02

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

247

0.97

0.01

1.4

1.2

—

(4015189)

266

0.98

0.00

3.7

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

146

1.03

0.00

1.3

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

176

1.02

0.00

1.3

1.1

0.8

0.2

u/ml

—

116

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

436

1.01

0.00

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

514

0.99

0.00

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

514

0.99

0.00

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

564

0.99

0.00

1.1

—

(3019174) dRVVT (LA screen)

118

1.02

0.00

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

448

4485

1.00

0.00

2.1

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

115

1.04

0.00

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

362

0.99

0.00

2.1

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

337

1.01

0.00

2.3

2.1

24199.7

808.3

e6/l

0.49

232

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

449

1.00

0.00

1.1

—

(3020491) Glucose [Moles/volume] in Blood

869

1.00

0.00

2.8

1.8

6.3

6.4

mmol/l

0.11

644

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.92

0.00

1.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.94

0.00

1.3

1.9

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.00

0.00

1.2

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

168.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.95

0.00

1.7

48.0

41.5

umol/l

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.00

0.00

1.3

1.6

1.2

0.8

umol/l

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.8

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

160

1.00

0.00

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.01

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC	0.957 [0.86, 1.06]	0.418
Birth year	0.995 [0.99, 1.0]	0.226

During the follow-up period (1.1.1998 — 31.12.2019), 2689 out of 38766 females with CD2_BENIGN_MELANOCYTIC died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC	0.961 [0.86, 1.07]	0.464
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 3060 out of 26073 males with CD2_BENIGN_MELANOCYTIC died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC.

N-year risk	Females	Males
1	0.083%	0.17%
5	0.555%	1.067%
10	1.39%	2.926%
15	2.67%	5.548%
20	4.581%	9.281%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC – Melanocytic naevi

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints